{"id": "spRDlWkAAAAJ", "citedby": 49396, "citedby5y": 29271, "hindex": 109, "hindex5y": 88, "i10index": 368, "i10index5y": 333, "coauthors": [{"id": "OX8BKIIAAAAJ", "name": "Jianming Zhang", "affiliation": "National Research Center for Translational Medicine, Shanghai Jiaotong University School of Medicine"}, {"id": "MgvB_nsAAAAJ", "name": "Laurent Meijer", "affiliation": ""}, {"id": "nnMDVmQAAAAJ", "name": "Priscilla L. Yang", "affiliation": "Associate Professor of Microbiology and Immunobiology, Harvard Medical School"}, {"id": "lRTRxSIAAAAJ", "name": "Richard Young", "affiliation": "Professor of Biology, MIT"}, {"id": "e6rwWLcAAAAJ", "name": "Ken Westover", "affiliation": "Associate Professor of Biochemistry and Radiation Oncology, UT Southwestern"}, {"id": "aE-VTpMAAAAJ", "name": "Stefan Knapp", "affiliation": "University of Frankfurt"}, {"id": "q6s4ZzAAAAAJ", "name": "Young-Tae Chang", "affiliation": "POSTECH"}, {"id": "wS6Ii_cAAAAJ", "name": "Peter K. Sorger", "affiliation": "Harvard Medical School"}, {"id": "kB__H-wAAAAJ", "name": "Ultan McDermott", "affiliation": "Faculty, Wellcome Trust Sanger Institute"}, {"id": "-OJ2lsYAAAAJ", "name": "John R. Engen", "affiliation": "James L. Waters Chair & Distinguished Professor, Northeastern University"}, {"id": "37lwQxMAAAAJ", "name": "Mario Niepel", "affiliation": "Instructor in Systems Biology, Harvard Medical School"}, {"id": "9L0V_o4AAAAJ", "name": "Zachary Hunter, PhD", "affiliation": "Dana-Farber Cancer Institute - Bing Center for WM"}, {"id": "W7Px5isAAAAJ", "name": "Deepak Gurbani", "affiliation": "Instructor, UT SOUTHWESTERN MEDICAL CENTER, DALLAS, TEXAS"}, {"id": "fop1IwgAAAAJ", "name": "Elizabeth A. Winzeler", "affiliation": "Professor, University of California San Diego, School of Medicine"}, {"id": "qujF-D4AAAAJ", "name": "Badry Bursulaya", "affiliation": "GNF"}, {"id": "5ZzCzlAAAAAJ", "name": "Craig Mermel", "affiliation": "Product Lead for Pathology, Google AI"}, {"id": "zH8dtMoAAAAJ", "name": "Roxana Iacob", "affiliation": "Research Associate Professor, Northeastern University"}, {"id": "HFJs76oAAAAJ", "name": "Daniel Lim", "affiliation": "MIT Koch Institute"}, {"id": "q-KRzawAAAAJ", "name": "Gad Getz", "affiliation": "Massachusetts General Hospital and Broad Institute of Harvard and MIT"}, {"id": "pAQSRSMAAAAJ", "name": "Simon Arthur", "affiliation": "University of Dundee"}], "name": "Nathanael Gray", "affiliation": "Professor of Biological Chemistry and Molecular Pharmacology, Harvard Medical School", "interests": ["medicinal chemistry", "cancer research", "structure-based drug design", "kinase inhibitors", "chemical biology"], "cites_per_year": {"1999": 129, "2000": 225, "2001": 279, "2002": 342, "2003": 456, "2004": 487, "2005": 527, "2006": 595, "2007": 634, "2008": 688, "2009": 1068, "2010": 1619, "2011": 2196, "2012": 2953, "2013": 3516, "2014": 3879, "2015": 4478, "2016": 4835, "2017": 5286, "2018": 5490, "2019": 6123, "2020": 3025}, "publications": [{"bib": {"title": "Targeting cancer with small molecule kinase inhibitors", "year": "2009"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:d1gkVwhDpl0C", "citedby": "2504"}, {"bib": {"title": "Systematic identification of genomic markers of drug sensitivity in cancer cells", "year": "2012"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:-FonjvnnhkoC", "citedby": "1732"}, {"bib": {"title": "An ATP-competitive mammalian target of rapamycin inhibitor reveals rapamycin-resistant functions of mTORC1", "year": "2009"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:2osOgNQ5qMEC", "citedby": "1529"}, {"bib": {"title": "DEPTOR is an mTOR inhibitor frequently overexpressed in multiple myeloma cells and required for their survival", "year": "2009"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:eQOLeE2rZwMC", "citedby": "1081"}, {"bib": {"title": "Exploiting chemical libraries, structure, and genomics in the search for kinase inhibitors", "year": "1998"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:u5HHmVD_uO8C", "citedby": "1037"}, {"bib": {"title": "A chemical switch for inhibitor-sensitive alleles of any protein kinase", "year": "2000"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:u-x6o8ySG0sC", "citedby": "1017"}, {"bib": {"title": "Rational design of inhibitors that bind to inactive kinase conformations", "year": "2006"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:qjMakFHDy7sC", "citedby": "1016"}, {"bib": {"title": "A unifying model for mTORC1-mediated regulation of mRNA translation", "year": "2012"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:9pM33mqn1YgC", "citedby": "1004"}, {"bib": {"title": "EML4-ALK fusion gene and efficacy of an ALK kinase inhibitor in lung cancer", "year": "2008"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:Tyk-4Ss8FVUC", "citedby": "984"}, {"bib": {"title": "The mTOR-regulated phosphoproteome reveals a mechanism of mTORC1-mediated inhibition of growth factor signaling", "year": "2011"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:e5wmG9Sq2KIC", "citedby": "884"}, {"bib": {"title": "Novel mutant-selective EGFR kinase inhibitors against EGFR T790M", "year": "2009"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:MXK_kJrjxJIC", "citedby": "880"}, {"bib": {"title": "Activating mutations in ALK provide a therapeutic target in neuroblastoma", "year": "2008"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:YsMSGLbcyi4C", "citedby": "787"}, {"bib": {"title": "Sphingosine 1-phosphate (S1P) receptor subtypes S1P1 and S1P3, respectively, regulate lymphocyte recirculation and heart rate", "year": "2004"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:9yKSN-GCB0IC", "citedby": "623"}, {"bib": {"title": "A landscape of pharmacogenomic interactions in cancer", "year": "2016"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:YFIp4goXIpYC", "citedby": "620"}, {"bib": {"title": "MEK1 mutations confer resistance to MEK and B-RAF inhibition", "year": "2009"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:M3ejUd6NZC8C", "citedby": "578"}, {"bib": {"title": "A novel ALK secondary mutation and EGFR signaling cause resistance to ALK kinase inhibitors", "year": "2011"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:lSLTfruPkqcC", "citedby": "554"}, {"bib": {"title": "A next generation connectivity map: L1000 platform and the first 1,000,000 profiles", "year": "2017"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:kSfMFMOdMMkC", "citedby": "535"}, {"bib": {"title": "Systematic identification of culture conditions for induction and maintenance of naive human pluripotency", "year": "2014"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:uUvzmPk0f8oC", "citedby": "523"}, {"bib": {"title": "Targeting Bcr\u2013Abl by combining allosteric with ATP-binding-site inhibitors", "year": "2010"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:8k81kl-MbHgC", "citedby": "500"}, {"bib": {"title": "Mutations in the DDR2 kinase gene identify a novel therapeutic target in squamous cell lung cancer", "year": "2011"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:JV2RwH3_ST0C", "citedby": "495"}, {"bib": {"title": "The promise and peril of chemical probes", "year": "2015"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:pRWBApOjXDcC", "citedby": "462"}, {"bib": {"title": "Synthetic small molecules that control stem cell fate", "year": "2003"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:IjCSPb-OGe4C", "citedby": "446"}, {"bib": {"title": "Developing irreversible inhibitors of the protein kinase cysteinome", "year": "2013"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:MpfHP-DdYjUC", "citedby": "442"}, {"bib": {"title": "Genomic alterations of anaplastic lymphoma kinase may sensitize tumors to anaplastic lymphoma kinase inhibitors", "year": "2008"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:roLk4NBRz8UC", "citedby": "441"}, {"bib": {"title": "In silico activity profiling reveals the mechanism of action of antimalarials discovered in a high-throughput screen", "year": "2008"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:YOwf2qJgpHMC", "citedby": "414"}, {"bib": {"title": "Targeting transcription regulation in cancer with a covalent CDK7 inhibitor", "year": "2014"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:JH5k92_tO-AC", "citedby": "404"}, {"bib": {"title": "Activation of tyrosine kinases by mutation of the gatekeeper threonine", "year": "2008"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:_kc_bZDykSQC", "citedby": "391"}, {"bib": {"title": "Inhibitor-sensitive FGFR1 amplification in human non-small cell lung cancer", "year": "2011"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:HoB7MX3m0LUC", "citedby": "380"}, {"bib": {"title": "Identification of NVP-TAE684, a potent, selective, and efficacious inhibitor of NPM-ALK", "year": "2007"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:hqOjcs7Dif8C", "citedby": "369"}, {"bib": {"title": "Roscovitine targets, protein kinases and pyridoxal kinase", "year": "2005"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:WF5omc3nYNoC", "citedby": "365"}, {"bib": {"title": "Allosteric inhibitors of Bcr-abl\u2013dependent cell proliferation", "year": "2006"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:LkGwnXOMwfcC", "citedby": "364"}, {"bib": {"title": "Identification of genotype-correlated sensitivity to selective kinase inhibitors by using high-throughput tumor cell line profiling", "year": "2007"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:UebtZRa9Y70C", "citedby": "354"}, {"bib": {"title": "ATP-site directed inhibitors of cyclin-dependent kinases", "year": "1999"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:UeHWp8X0CEIC", "citedby": "343"}, {"bib": {"title": "Synthesis and application of functionally diverse 2, 6, 9-trisubstituted purine libraries as CDK inhibitors", "year": "1999"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:zYLM7Y9cAGgC", "citedby": "338"}, {"bib": {"title": "Factors underlying sensitivity of cancers to small-molecule kinase inhibitors", "year": "2009"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:ULOm3_A8WrAC", "citedby": "325"}, {"bib": {"title": "Characterization of a selective inhibitor of the Parkinson's disease kinase LRRK2", "year": "2011"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:O3NaXMp0MMsC", "citedby": "316"}, {"bib": {"title": "mTORC1 phosphorylation sites encode their sensitivity to starvation and rapamycin", "year": "2013"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:g5Ck-dwhA_QC", "citedby": "314"}, {"bib": {"title": "CDK7 inhibition suppresses super-enhancer-linked oncogenic transcription in MYCN-driven cancer", "year": "2014"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:u3T1itk59dMC", "citedby": "307"}, {"bib": {"title": "The neuroblastoma-associated F1174L ALK mutation causes resistance to an ALK kinase inhibitor in ALK-translocated cancers", "year": "2010"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:4JMBOYKVnBMC", "citedby": "307"}, {"bib": {"title": "Synthesis, Structure\u2013Activity Relationships, and in Vivo Efficacy of the Novel Potent and Selective Anaplastic Lymphoma Kinase (ALK) Inhibitor 5-Chloro-N2-(2-isopropoxy-5 \u2026", "year": "2013"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:raTqNPD5sRQC", "citedby": "296"}, {"bib": {"title": "YY1 is a structural regulator of enhancer-promoter loops", "year": "2017"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:iWMWD4ieBCcC", "citedby": "287"}, {"bib": {"title": "Intracellular targets of cyclin-dependent kinase inhibitors: identification by affinity chromatography using immobilised inhibitors", "year": "2000"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:Y0pCki6q_DkC", "citedby": "281"}, {"bib": {"title": "Small molecules that induce cardiomyogenesis in embryonic stem cells", "year": "2004"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:_FxGoFyzp5QC", "citedby": "270"}, {"bib": {"title": "A combinatorial scaffold approach toward kinase-directed heterocycle libraries", "year": "2002"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:ufrVoPGSRksC", "citedby": "270"}, {"bib": {"title": "A mutation in MYD88 (L265P) supports the survival of lymphoplasmacytic cells by activation of Bruton tyrosine kinase in Waldenstr\u00f6m macroglobulinemia", "year": "2013"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:SGW5VrABaM0C", "citedby": "269"}, {"bib": {"title": "The immunological evolution of catalysis", "year": "1996"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:W7OEmFMy1HYC", "citedby": "267"}, {"bib": {"title": "In situ kinase profiling reveals functionally relevant properties of native kinases", "year": "2011"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:KxtntwgDAa4C", "citedby": "255"}, {"bib": {"title": "Cap-binding complex (CBC)", "year": "2014"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:TesyEGJKHF4C", "citedby": "248"}, {"bib": {"title": "Reactivation of ERK signaling causes resistance to EGFR kinase inhibitors", "year": "2012"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:dBIO0h50nwkC", "citedby": "244"}, {"bib": {"title": "Response and acquired resistance to everolimus in anaplastic thyroid cancer", "year": "2014"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:4n0clTBhZ78C", "citedby": "242"}, {"bib": {"title": "Exploration of type II binding mode: a privileged approach for kinase inhibitor focused drug discovery?", "year": "2014"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:KI9T_ytC6pkC", "citedby": "241"}, {"bib": {"title": "EGFR mutations and resistance to irreversible pyrimidine-based EGFR inhibitors", "year": "2015"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:eFf2swCANGcC", "citedby": "239"}, {"bib": {"title": "Targeting transcriptional addictions in small cell lung cancer with a covalent CDK7 inhibitor", "year": "2014"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:c1AJUTjuCtUC", "citedby": "234"}, {"bib": {"title": "The ALKF1174L mutation potentiates the oncogenic activity of MYCN in neuroblastoma", "year": "2012"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:XvxMoLDsR5gC", "citedby": "231"}, {"bib": {"title": "Therapeutic targeting of oncogenic K\u2010Ras by a covalent catalytic site inhibitor", "year": "2014"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:RMgMIBzvq-4C", "citedby": "228"}, {"bib": {"title": "The evolving war on cancer", "year": "2011"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:RGFaLdJalmkC", "citedby": "227"}, {"bib": {"title": "Discovery of potent and selective covalent inhibitors of JNK", "year": "2012"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:D_sINldO8mEC", "citedby": "225"}, {"bib": {"title": "A small molecule with osteogenesis-inducing activity in multipotent mesenchymal progenitor cells", "year": "2002"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:5nxA0vEk-isC", "citedby": "225"}, {"bib": {"title": "Oncogenic PIK3CA-driven mammary tumors frequently recur via PI3K pathway\u2013dependent and PI3K pathway\u2013independent mechanisms", "year": "2011"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:fPk4N6BV_jEC", "citedby": "223"}, {"bib": {"title": "Kinase inhibitors: the road ahead", "year": "2018"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:iiZUkH1jxVAC", "citedby": "222"}, {"bib": {"title": "Small-molecule kinase inhibitors provide insight into Mps1 cell cycle function", "year": "2010"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:TQgYirikUcIC", "citedby": "218"}, {"bib": {"title": "The selective sphingosine 1\u2010phosphate receptor modulator BAF312 redirects lymphocyte distribution and has species\u2010specific effects on heart rate", "year": "2012"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:_FM0Bhl9EiAC", "citedby": "205"}, {"bib": {"title": "Gene expression signatures and small-molecule compounds link a protein kinase to Plasmodium falciparum motility", "year": "2008"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:aqlVkmm33-oC", "citedby": "203"}, {"bib": {"title": "Inhibition of ALK, PI3K/MEK, and HSP90 in murine lung adenocarcinoma induced by EML4-ALK fusion oncogene", "year": "2010"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:k_IJM867U9cC", "citedby": "202"}, {"bib": {"title": "CDK7-dependent transcriptional addiction in triple-negative breast cancer", "year": "2015"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:Nnq8S6OXqDYC", "citedby": "200"}, {"bib": {"title": "High-throughput kinase profiling as a platform for drug discovery", "year": "2008"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:4DMP91E08xMC", "citedby": "200"}, {"bib": {"title": "CVT-313, a specific and potent inhibitor of CDK2 that prevents neointimal proliferation", "year": "1997"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:Se3iqnhoufwC", "citedby": "192"}, {"bib": {"title": "mTOR mediated anti-cancer drug discovery", "year": "2009"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:GnPB-g6toBAC", "citedby": "188"}, {"bib": {"title": "Small molecule modulators of antioxidant response pathway", "year": "2011"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:dfsIfKJdRG4C", "citedby": "180"}, {"bib": {"title": "Discovery of 1-(4-(4-Propionylpiperazin-1-yl)-3-(trifluoromethyl)phenyl)-9-(quinolin-3-yl)benzo[h][1,6]naphthyridin-2(1H)-one as a Highly Potent, Selective \u2026", "year": "2010"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:ns9cj8rnVeAC", "citedby": "179"}, {"bib": {"title": "Golgicide A reveals essential roles for GBF1 in Golgi assembly and function", "year": "2009"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:_Qo2XoVZTnwC", "citedby": "179"}, {"bib": {"title": "An efficient rapid system for profiling the cellular activities of molecular libraries", "year": "2006"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:3fE2CSJIrl8C", "citedby": "176"}, {"bib": {"title": "Resistance to irreversible EGF receptor tyrosine kinase inhibitors through a multistep mechanism involving the IGF1R pathway", "year": "2013"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:fFSKOagxvKUC", "citedby": "174"}, {"bib": {"title": "Discovery of 9-(6-Aminopyridin-3-yl)-1-(3-(trifluoromethyl)phenyl)benzo[h][1,6]naphthyridin-2(1H)-one (Torin2) as a Potent, Selective, and Orally Available \u2026", "year": "2011"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:EUQCXRtRnyEC", "citedby": "168"}, {"bib": {"title": "Screening of DUB activity and specificity by MALDI-TOF mass spectrometry", "year": "2014"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:SpPTWFSNUtQC", "citedby": "166"}, {"bib": {"title": "Phosphorylation of CRTC3 by the salt-inducible kinases controls the interconversion of classically activated and regulatory macrophages", "year": "2012"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:cWzG1nlazyYC", "citedby": "165"}, {"bib": {"title": "The ins and outs of selective kinase inhibitor development", "year": "2015"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:MGPUR4WVBMEC", "citedby": "163"}, {"bib": {"title": "A structure-guided approach to creating covalent FGFR inhibitors", "year": "2010"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:ldfaerwXgEUC", "citedby": "162"}, {"bib": {"title": "A PHGDH inhibitor reveals coordination of serine synthesis and one-carbon unit fate", "year": "2016"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:A_Q71aBZDscC", "citedby": "159"}, {"bib": {"title": "A structure-based library approach to kinase inhibitors", "year": "1996"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:0EnyYjriUFMC", "citedby": "158"}, {"bib": {"title": "Inhibitor-sensitive FGFR2 and FGFR3 mutations in lung squamous cell carcinoma", "year": "2013"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:kzcSZmkxUKAC", "citedby": "157"}, {"bib": {"title": "A general strategy for creating \u201cinactive-conformation\u201d abl inhibitors", "year": "2006"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:KlAtU1dfN6UC", "citedby": "157"}, {"bib": {"title": "Pharmacological inhibition of BMK1 suppresses tumor growth through promyelocytic leukemia protein", "year": "2010"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:35N4QoGY0k4C", "citedby": "156"}, {"bib": {"title": "Functional characterization of an isoform-selective inhibitor of PI3K-p110\u03b2 as a potential anticancer agent", "year": "2012"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:YohjEiUPhakC", "citedby": "146"}, {"bib": {"title": "Synthesis and target identification of hymenialdisine analogs", "year": "2004"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:Zph67rFs4hoC", "citedby": "146"}, {"bib": {"title": "The IkappaB kinase family phosphorylates the Parkinson\u2019s disease kinase LRRK2 at Ser935 and Ser910 during Toll-like receptor signaling", "year": "2012"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:LO7wyVUgiFcC", "citedby": "142"}, {"bib": {"title": "Acquired resistance of non\u2013small cell lung cancer cells to MET kinase inhibition is mediated by a switch to epidermal growth factor receptor dependency", "year": "2010"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:r0BpntZqJG4C", "citedby": "142"}, {"bib": {"title": "In situ selectivity profiling and crystal structure of SML-8-73-1, an active site inhibitor of oncogenic K-Ras G12C", "year": "2014"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:QaSi33NTfwYC", "citedby": "141"}, {"bib": {"title": "SRC family kinases: potential targets for the treatment of human cancer and leukemia", "year": "2003"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:kNdYIx-mwKoC", "citedby": "140"}, {"bib": {"title": "King penguin population threatened by Southern Ocean warming", "year": "2008"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:yFnVuubrUp4C", "citedby": "139"}, {"bib": {"title": "Combined EGFR/MEK inhibition prevents the emergence of resistance in EGFR-mutant lung cancer", "year": "2015"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:kO05sadLmrgC", "citedby": "138"}, {"bib": {"title": "Characterization of Torin2, an ATP-competitive inhibitor of mTOR, ATM, and ATR", "year": "2013"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:LdasjJ6CEcoC", "citedby": "133"}, {"bib": {"title": "A public-private partnership to unlock the untargeted kinome", "year": "2012"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:ubry08Y2EpUC", "citedby": "128"}, {"bib": {"title": "BET bromodomain proteins function as master transcription elongation factors independent of CDK9 recruitment", "year": "2017"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:NXa0JjR8Cs8C", "citedby": "126"}, {"bib": {"title": "Combinatorial synthesis of 2, 9-substituted purines", "year": "1997"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:qxL8FJ1GzNcC", "citedby": "124"}, {"bib": {"title": "YAP drives growth by controlling transcriptional pause release from dynamic enhancers", "year": "2015"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:GJVTs2krol4C", "citedby": "123"}, {"bib": {"title": "CDK4/6 inhibition augments antitumor immunity by enhancing T-cell activation", "year": "2018"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:Yc4pXcQx_ZsC", "citedby": "121"}, {"bib": {"title": "FLT3 inhibition and mechanisms of drug resistance in mutant FLT3-positive AML", "year": "2009"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:bEWYMUwI8FkC", "citedby": "121"}, {"bib": {"title": "Identification of human kinases involved in hepatitis C virus replication by small interference RNA library screening", "year": "2008"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:ZeXyd9-uunAC", "citedby": "121"}, {"bib": {"title": "The library of integrated network-based cellular signatures NIH program: system-level cataloging of human cells response to perturbations", "year": "2018"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:sTSjfTwc8rsC", "citedby": "119"}, {"bib": {"title": "Pharmacological cyclin-dependent kinase inhibitors inhibit replication of wild-type and drug-resistant strains of herpes simplex virus and human immunodeficiency virus type 1 \u2026", "year": "2002"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:4TOpqqG69KYC", "citedby": "118"}, {"bib": {"title": "GSK2578215A; a potent and highly selective 2-arylmethyloxy-5-substitutent-N-arylbenzamide LRRK2 kinase inhibitor", "year": "2012"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:a9-T7VOCCH8C", "citedby": "117"}, {"bib": {"title": "A unique inhibitor binding site in ERK1/2 is associated with slow binding kinetics", "year": "2014"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:cNe27ouKFcQC", "citedby": "116"}, {"bib": {"title": "A monoselective sphingosine-1-phosphate receptor-1 agonist prevents allograft rejection in a stringent rat heart transplantation model", "year": "2006"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:qUcmZB5y_30C", "citedby": "116"}, {"bib": {"title": "A genome-wide overexpression screen in yeast for small-molecule target identification", "year": "2005"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:7PzlFSSx8tAC", "citedby": "115"}, {"bib": {"title": "Covalent targeting of remote cysteine residues to develop CDK12 and CDK13 inhibitors", "year": "2016"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:ybgmOu3m07wC", "citedby": "114"}, {"bib": {"title": "Pharmacological perturbation of CDK9 using selective CDK9 inhibition or degradation", "year": "2018"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:DFCteqpGOQ8C", "citedby": "113"}, {"bib": {"title": "Development of covalent inhibitors that can overcome resistance to first-generation FGFR kinase inhibitors", "year": "2014"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:SrKkpNFED5gC", "citedby": "111"}, {"bib": {"title": "A chemoproteomic approach to query the degradable kinome using a multi-kinase degrader", "year": "2018"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:Yp7c5zGSQR8C", "citedby": "110"}, {"bib": {"title": "Novel compounds and compositions as protein kinase inhibitors", "year": "2005"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:dTyEYWd-f8wC", "citedby": "109"}, {"bib": {"title": "Pharmacological targeting of kinases MST1 and MST2 augments tissue repair and regeneration", "year": "2016"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:B06RkWtwG_wC", "citedby": "105"}, {"bib": {"title": "The dTAG system for immediate and target-specific protein degradation", "year": "2018"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:vKvsjmpZL3QC", "citedby": "102"}, {"bib": {"title": "Chaperones as thermodynamic sensors of drug-target interactions reveal kinase inhibitor specificities in living cells", "year": "2013"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:An6A6Jpfc1oC", "citedby": "100"}, {"bib": {"title": "Pharmacological targeting of the pseudokinase Her3", "year": "2014"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:lK9BDNCuzFgC", "citedby": "98"}, {"bib": {"title": "Discovery of a potent and selective DDR1 receptor tyrosine kinase inhibitor", "year": "2013"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:c1e4I3QdEKYC", "citedby": "98"}, {"bib": {"title": "The LKB1-salt-inducible kinase pathway functions as a key gluconeogenic suppressor in the liver", "year": "2014"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:BJtnxTr0fRcC", "citedby": "97"}, {"bib": {"title": "Small-molecule inhibitors of USP1 target ID1 degradation in leukemic cells", "year": "2013"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:L24QuVWYgZ0C", "citedby": "96"}, {"bib": {"title": "Brain penetrant LRRK2 inhibitor", "year": "2012"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:anf4URPfarAC", "citedby": "96"}, {"bib": {"title": "2, 4-pyrimidinediamines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders", "year": "2011"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:evX43VCCuoAC", "citedby": "96"}, {"bib": {"title": "Expanding the diversity of purine libraries", "year": "2001"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:dhFuZR0502QC", "citedby": "93"}, {"bib": {"title": "Kinome-wide selectivity profiling of ATP-competitive mammalian target of rapamycin (mTOR) inhibitors and characterization of their binding kinetics", "year": "2012"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:g3aElNc5_aQC", "citedby": "92"}, {"bib": {"title": "TYK2\u2013STAT1\u2013BCL2 pathway dependence in T-cell acute lymphoblastic leukemia", "year": "2013"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:nRpfm8aw39MC", "citedby": "91"}, {"bib": {"title": "High-throughput kinase profiling: a more efficient approach toward the discovery of new kinase inhibitors", "year": "2011"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:CHSYGLWDkRkC", "citedby": "90"}, {"bib": {"title": "Compounds and compositions as inhibitors of receptor tyrosine kinase activity", "year": "2005"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:pUxgyZctzPYC", "citedby": "89"}, {"bib": {"title": "EGFR inhibitors and methods of treating disorders", "year": "2018"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:4fGpz3EwCPoC", "citedby": "88"}, {"bib": {"title": "Discovery of estrogen sulfotransferase inhibitors from a purine library screen", "year": "2001"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:Wp0gIr-vW9MC", "citedby": "87"}, {"bib": {"title": "Plasticity in binding confers selectivity in ligand-induced protein degradation", "year": "2018"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:iYlpbnUWyFkC", "citedby": "86"}, {"bib": {"title": "A concise and traceless linker strategy toward combinatorial libraries of 2, 6, 9-substituted purines", "year": "2001"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:IWHjjKOFINEC", "citedby": "86"}, {"bib": {"title": "Metabolic and functional genomic studies identify deoxythymidylate kinase as a target in LKB1-mutant lung cancer", "year": "2013"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:ziOE8S1-AIUC", "citedby": "85"}, {"bib": {"title": "Identification of coumarin derivatives as a novel class of allosteric MEK1 inhibitors", "year": "2005"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:iH-uZ7U-co4C", "citedby": "85"}, {"bib": {"title": "Design of allele-specific protein methyltransferase inhibitors", "year": "2001"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:R3hNpaxXUhUC", "citedby": "84"}, {"bib": {"title": "Purine compounds and compositions as kinase inhibitors for the treatment of plasmodium related diseases", "year": "2010"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:bnK-pcrLprsC", "citedby": "83"}, {"bib": {"title": "Immunosuppressant compounds and compositions", "year": "2009"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:ML0RJ9NH7IQC", "citedby": "83"}, {"bib": {"title": "Resin-capture and release strategy toward combinatorial libraries of 2, 6, 9-substituted purines", "year": "2002"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:L8Ckcad2t8MC", "citedby": "83"}, {"bib": {"title": "Discovery of carbohydrate sulfotransferase inhibitors from a kinase\u2010directed library", "year": "2000"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:9ZlFYXVOiuMC", "citedby": "83"}, {"bib": {"title": "Effects of the selective MPS1 inhibitor MPS1-IN-3 on glioblastoma sensitivity to antimitotic drugs", "year": "2013"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:37UQlXuwjP4C", "citedby": "82"}, {"bib": {"title": "2, 4-di (phenylamino) pyrimidines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders", "year": "2011"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:JoZmwDi-zQgC", "citedby": "81"}, {"bib": {"title": "Clinical stage EGFR inhibitors irreversibly alkylate Bmx kinase", "year": "2008"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:4OULZ7Gr8RgC", "citedby": "81"}, {"bib": {"title": "p42/p44 MAPKs are intracellular targets of the CDK inhibitor purvalanol", "year": "2002"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:QIV2ME_5wuYC", "citedby": "81"}, {"bib": {"title": "Discovery of BAF312 (siponimod), a potent and selective S1P receptor modulator", "year": "2013"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:43bX7VzcjpAC", "citedby": "80"}, {"bib": {"title": "A cyclin-dependent kinase inhibitor inducing cancer cell differentiation: biochemical identification using Xenopus egg extracts", "year": "1999"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:mVmsd5A6BfQC", "citedby": "80"}, {"bib": {"title": "Compounds and compositions as protein kinase inhibitors", "year": "2013"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:a0OBvERweLwC", "citedby": "78"}, {"bib": {"title": "Compounds and compositions as protein kinase inhibitors", "year": "2010"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:dshw04ExmUIC", "citedby": "77"}, {"bib": {"title": "Crystal structure of pyridoxal kinase in complex with roscovitine and derivatives", "year": "2005"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:HDshCWvjkbEC", "citedby": "74"}, {"bib": {"title": "Discovery of a small-molecule type II inhibitor of wild-type and gatekeeper mutants of BCR-ABL, PDGFR\u03b1, Kit, and Src kinases: novel type II inhibitor of gatekeeper mutants", "year": "2010"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:blknAaTinKkC", "citedby": "73"}, {"bib": {"title": "Fibroblast growth factor receptor 1\u2013transformed mammary epithelial cells are dependent on RSK activity for growth and survival", "year": "2009"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:maZDTaKrznsC", "citedby": "73"}, {"bib": {"title": "Conformational disturbance in Abl kinase upon mutation and deregulation", "year": "2009"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:TFP_iSt0sucC", "citedby": "73"}, {"bib": {"title": "Design and synthesis of 7H-pyrrolo [2, 3-d] pyrimidines as focal adhesion kinase inhibitors. Part 2", "year": "2006"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:isC4tDSrTZIC", "citedby": "72"}, {"bib": {"title": "Characterization of TAE684 as a potent LRRK2 kinase inhibitor", "year": "2012"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:86PQX7AUzd4C", "citedby": "71"}, {"bib": {"title": "Antimitotic agents of natural origin", "year": "2006"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:NMxIlDl6LWMC", "citedby": "71"}, {"bib": {"title": "Allele-specific chromatin recruitment and therapeutic vulnerabilities of ESR1 activating mutations", "year": "2018"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:Eqg1ddRpejoC", "citedby": "70"}, {"bib": {"title": "Inhibiting fungal multidrug resistance by disrupting an activator\u2013mediator interaction", "year": "2016"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:r0ARIG2f-gUC", "citedby": "70"}, {"bib": {"title": "Identification of a novel protein regulating microtubule stability through a chemical approach", "year": "2004"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:-f6ydRqryjwC", "citedby": "70"}, {"bib": {"title": "Systematic analysis of BRAFV600E melanomas reveals a role for JNK/c\u2010Jun pathway in adaptive resistance to drug\u2010induced apoptosis", "year": "2015"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:S2WlVNSe3u4C", "citedby": "69"}, {"bib": {"title": "MELK is an oncogenic kinase essential for mitotic progression in basal-like breast cancer cells", "year": "2014"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:60iIaj97TE0C", "citedby": "69"}, {"bib": {"title": "A small-molecule inducer of the antioxidant response element", "year": "2010"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:_xSYboBqXhAC", "citedby": "69"}, {"bib": {"title": "Compounds that modulate egfr activity and methods for treating or preventing conditions therewith", "year": "2011"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:gVv57TyPmFsC", "citedby": "68"}, {"bib": {"title": "EPHA2 is a mediator of vemurafenib resistance and a novel therapeutic target in melanoma", "year": "2015"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:X5YyAB84Iw4C", "citedby": "66"}, {"bib": {"title": "Structure-activity relationships and inhibitory effects of various purine derivatives on the in vitro growth of Plasmodium falciparum", "year": "2001"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:hC7cP41nSMkC", "citedby": "66"}, {"bib": {"title": "Progress towards a public chemogenomic set for protein kinases and a call for contributions", "year": "2017"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:cOP-uZQ6k_YC", "citedby": "65"}, {"bib": {"title": "Salt-inducible kinase 2 couples ovarian cancer cell metabolism with survival at the adipocyte-rich metastatic niche", "year": "2016"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:324HgoyA9qIC", "citedby": "65"}, {"bib": {"title": "The kinase ALK stimulates the kinase ERK5 to promote the expression of the oncogene MYCN in neuroblastoma", "year": "2014"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:EBV337fEn3EC", "citedby": "65"}, {"bib": {"title": "Solid-phase synthesis of 2, 3, 5-trisubstituted indoles", "year": "2001"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:hFOr9nPyWt4C", "citedby": "65"}, {"bib": {"title": "Discovery and structural analysis of Eph receptor tyrosine kinase inhibitors", "year": "2009"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:M05iB0D1s5AC", "citedby": "64"}, {"bib": {"title": "Functional TRIM24 degrader via conjugation of ineffectual bromodomain and VHL ligands", "year": "2018"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:_lZPlZTPtRIC", "citedby": "63"}, {"bib": {"title": "Genetic and pharmacologic inhibition of EPHA2 promotes apoptosis in NSCLC", "year": "2014"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:TGkaJS32XoUC", "citedby": "63"}, {"bib": {"title": "PIM kinases are essential for chronic lymphocytic leukemia cell survival (PIM2/3) and CXCR4-mediated microenvironmental interactions (PIM1)", "year": "2014"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:3A3nxV7CjKIC", "citedby": "62"}, {"bib": {"title": "Protein kinase IKK\u03b2-catalyzed phosphorylation of IRF5 at Ser462 induces its dimerization and nuclear translocation in myeloid cells", "year": "2014"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:i_7YvbSbtFEC", "citedby": "61"}, {"bib": {"title": "Allosteric interactions between the myristate-and ATP-site of the Abl kinase", "year": "2011"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:D03iK_w7-QYC", "citedby": "61"}, {"bib": {"title": "Molecular rationale for the use of PI3K/AKT/mTOR pathway inhibitors in combination with crizotinib in ALK-mutated neuroblastoma", "year": "2014"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:RfUwGJFMQ-0C", "citedby": "60"}, {"bib": {"title": "Discovery of selective irreversible inhibitors for EGFR-T790M", "year": "2011"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:nb7KW1ujOQ8C", "citedby": "60"}, {"bib": {"title": "Purine\u2010based inhibitors of inositol\u20101, 4, 5\u2010trisphosphate\u20103\u2010kinase", "year": "2002"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:j3f4tGmQtD8C", "citedby": "60"}, {"bib": {"title": "Synthesis and biological evaluation of myoseverin derivatives: microtubule assembly inhibitors", "year": "2001"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:RHpTSmoSYBkC", "citedby": "60"}, {"bib": {"title": "Development of selective covalent janus kinase 3 inhibitors", "year": "2015"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:oldoQiaHq2UC", "citedby": "59"}, {"bib": {"title": "Using combination therapy to override stromal-mediated chemoresistance in mutant FLT3-positive AML: synergism between FLT3 inhibitors, dasatinib/multi-targeted inhibitors and \u2026", "year": "2012"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:WA5NYHcadZ8C", "citedby": "59"}, {"bib": {"title": "A type-II kinase inhibitor capable of inhibiting the T315I \u201cgatekeeper\u201d mutant of Bcr-Abl", "year": "2010"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:pqnbT2bcN3wC", "citedby": "58"}, {"bib": {"title": "ALK inhibitor resistance in ALK F1174L-driven neuroblastoma is associated with AXL activation and induction of EMT", "year": "2016"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:Gp7G-LMh-YMC", "citedby": "57"}, {"bib": {"title": "Structural mechanisms determining inhibition of the collagen receptor DDR1 by selective and multi-targeted type II kinase inhibitors", "year": "2014"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:xyvS_IvSCKsC", "citedby": "57"}, {"bib": {"title": "Inhibitors of the Abl kinase directed at either the ATP-or myristate-binding site", "year": "2010"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:2P1L_qKh6hAC", "citedby": "56"}, {"bib": {"title": "HCK is a survival determinant transactivated by mutated MYD88, and a direct target of ibrutinib", "year": "2016"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:gTm0F0ptQfkC", "citedby": "55"}, {"bib": {"title": "Expanding the diversity of allosteric bcr-abl inhibitors", "year": "2010"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:u9iWguZQMMsC", "citedby": "55"}, {"bib": {"title": "Discovery of EGFR selective 4, 6-disubstituted pyrimidines from a combinatorial kinase-directed heterocycle library", "year": "2006"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:YFjsv_pBGBYC", "citedby": "54"}, {"bib": {"title": "A non-canonical SWI/SNF complex is a synthetic lethal target in cancers driven by BAF complex perturbation", "year": "2018"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:2OH0MCcz6qcC", "citedby": "53"}, {"bib": {"title": "Vehicle measuring apparatus and method for toll collection system", "year": "2005"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:pawnNKgKThcC", "citedby": "53"}, {"bib": {"title": "Apparatus and method for measuring molecular electromagnetic signals with a squid device and stochastic resonance to measure low-threshold signals", "year": "2004"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:k1VWYO0b_yEC", "citedby": "53"}, {"bib": {"title": "SIKs control osteocyte responses to parathyroid hormone", "year": "2016"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:WL77y43GR6IC", "citedby": "52"}, {"bib": {"title": "TSC1 involvement in bladder cancer: diverse effects and therapeutic implications", "year": "2013"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:kVjdVfd2voEC", "citedby": "52"}, {"bib": {"title": "N-myristoylated c-Abl tyrosine kinase localizes to the endoplasmic reticulum upon binding to an allosteric inhibitor", "year": "2009"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:ZHo1McVdvXMC", "citedby": "52"}, {"bib": {"title": "Systematic kinome shRNA screening identifies CDK11 (PITSLRE) kinase expression is critical for osteosarcoma cell growth and proliferation", "year": "2012"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:sNmaIFBj_lkC", "citedby": "51"}, {"bib": {"title": "Identification of existing drugs that effectively target NTRK1 and ROS1 rearrangements in lung cancer", "year": "2017"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:_obbd28Je0oC", "citedby": "50"}, {"bib": {"title": "EPHA2 blockade overcomes acquired resistance to EGFR kinase inhibitors in lung cancer", "year": "2016"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:xV_PwZns_iUC", "citedby": "50"}, {"bib": {"title": "Design and synthesis of 7H-pyrrolo [2, 3-d] pyrimidines as focal adhesion kinase inhibitors. Part 1", "year": "2006"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:J_g5lzvAfSwC", "citedby": "50"}, {"bib": {"title": "Potent and selective covalent quinazoline inhibitors of KRAS G12C", "year": "2017"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:etrBy31LU9kC", "citedby": "49"}, {"bib": {"title": "Structure of the human cGAS\u2013DNA complex reveals enhanced control of immune surveillance", "year": "2018"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:WP_jKstdCMYC", "citedby": "48"}, {"bib": {"title": "Activation of HIPK2 promotes ER stress-mediated neurodegeneration in amyotrophic lateral sclerosis", "year": "2016"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:vqiJ1fI9etEC", "citedby": "48"}, {"bib": {"title": "Chemical and biological profile of dual Cdk1 and Cdk2 inhibitors", "year": "2003"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:mB3voiENLucC", "citedby": "48"}, {"bib": {"title": "THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors", "year": "2017"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:w48piNt9QLsC", "citedby": "47"}, {"bib": {"title": "Discovery of type II inhibitors of TGF\u03b2-activated kinase 1 (TAK1) and mitogen-activated protein kinase kinase kinase kinase 2 (MAP4K2)", "year": "2015"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:h168fVGZblEC", "citedby": "47"}, {"bib": {"title": "Discovery of a benzo [e] pyrimido-[5, 4-b][1, 4] diazepin-6 (11H)-one as a Potent and Selective Inhibitor of Big MAP Kinase 1", "year": "2011"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:p2g8aNsByqUC", "citedby": "47"}, {"bib": {"title": "Compounds and Compositions as Protein Kinase Inhibitors", "year": "2008"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:EYYDruWGBe4C", "citedby": "47"}, {"bib": {"title": "Discovery of a potent, covalent BTK inhibitor for B-cell lymphoma", "year": "2014"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:XDrR66g3YHsC", "citedby": "46"}, {"bib": {"title": "Ligand-associated ERBB2/3 activation confers acquired resistance to FGFR inhibition in FGFR3-dependent cancer cells", "year": "2015"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:E7VqQtBCVmcC", "citedby": "45"}, {"bib": {"title": "Kinase inhibitor scaffolds and methods for their preparation", "year": "2007"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:KaMxkj08jr0C", "citedby": "44"}, {"bib": {"title": "Selective Akt inhibitors synergize with tyrosine kinase inhibitors and effectively override stroma-associated cytoprotection of mutant FLT3-positive AML cells", "year": "2013"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:PaBasH6fAo0C", "citedby": "42"}, {"bib": {"title": "Discovery of selective aminothiazole aurora kinase inhibitors", "year": "2008"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:hMod-77fHWUC", "citedby": "42"}, {"bib": {"title": "The mitogen-activated protein kinase ERK5 regulates the development and growth of hepatocellular carcinoma", "year": "2015"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:Ej9njvOgR2oC", "citedby": "41"}, {"bib": {"title": "Identification of Wee1 as a novel therapeutic target for mutant RAS-driven acute leukemia and other malignancies", "year": "2015"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:0sTkTiv_uMkC", "citedby": "41"}, {"bib": {"title": "Compounds and compositions as protein kinase inhibitors", "year": "2008"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:eq2jaN3J8jMC", "citedby": "41"}, {"bib": {"title": "Chemically induced degradation of anaplastic lymphoma kinase (ALK)", "year": "2018"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:TPcLtUTv7sEC", "citedby": "40"}, {"bib": {"title": "Tivantinib (ARQ 197) efficacy is independent of MET inhibition in non-small-cell lung cancer cell lines", "year": "2015"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:sbeIDTyQOFgC", "citedby": "40"}, {"bib": {"title": "Small-molecule screening identifies inhibition of salt-inducible kinases as a therapeutic strategy to enhance immunoregulatory functions of dendritic cells", "year": "2014"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:hHIA4WEVY-EC", "citedby": "40"}, {"bib": {"title": "A ceramide\u20101\u2010phosphate analogue, PCERA\u20101, simultaneously suppresses tumour necrosis factor\u2010\u03b1 and induces interleukin\u201010 production in activated macrophages", "year": "2009"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:NaGl4SEjCO4C", "citedby": "40"}, {"bib": {"title": "Covalent guanosine mimetic inhibitors of G12C KRAS", "year": "2017"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:Liyi5BL3lGIC", "citedby": "39"}, {"bib": {"title": "Acquired resistance to dasatinib in lung cancer cell lines conferred by DDR2 gatekeeper mutation and NF1 loss", "year": "2014"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:I8rxH6phXEkC", "citedby": "39"}, {"bib": {"title": "Leucine-rich repeat kinase 2 inhibitors: a patent review (2006\u20132011)", "year": "2012"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:ODE9OILHJdcC", "citedby": "39"}, {"bib": {"title": "Inhibition of USP10 induces degradation of oncogenic FLT3", "year": "2017"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:yj0jDpv2chsC", "citedby": "37"}, {"bib": {"title": "Discovery of pyrimidine benzimidazoles as Lck inhibitors: Part I", "year": "2008"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:70eg2SAEIzsC", "citedby": "37"}, {"bib": {"title": "Verification of a designed intramolecular hydrogen bond in a drug scaffold by nuclear magnetic resonance spectroscopy", "year": "2007"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:bFI3QPDXJZMC", "citedby": "37"}, {"bib": {"title": "Immunosuppressant compounds and compositions", "year": "2006"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:u_35RYKgDlwC", "citedby": "37"}, {"bib": {"title": "Creating chemical diversity to target protein kinases", "year": "2004"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:BqipwSGYUEgC", "citedby": "37"}, {"bib": {"title": "Identification of homeodomain proteins, PBX1 and PREP1, involved in the transcription of murine leukemia virus", "year": "2003"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:M3NEmzRMIkIC", "citedby": "37"}, {"bib": {"title": "Homolog-Selective Degradation as a Strategy to Probe the Function of CDK6 in AML", "year": "2019"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:xpOcSxJuMv8C", "citedby": "36"}, {"bib": {"title": "Suppression of adaptive responses to targeted cancer therapy by transcriptional repression", "year": "2018"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:2YKEWf8Wbo8C", "citedby": "36"}, {"bib": {"title": "Mitotic MELK-eIF4B signaling controls protein synthesis and tumor cell survival", "year": "2016"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:nlk6zB4cO3MC", "citedby": "36"}, {"bib": {"title": "Substituted pyrrolo [2, 3-2] pyrimidines as protein kinase inhibitors", "year": "2011"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:SeFeTyx0c_EC", "citedby": "36"}, {"bib": {"title": "Covalent targeting of fibroblast growth factor receptor inhibits metastatic breast cancer", "year": "2016"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:zAyHUgvcU_QC", "citedby": "35"}, {"bib": {"title": "Structural determinants for ERK5 (MAPK7) and leucine rich repeat kinase 2 activities of benzo [e] pyrimido-[5, 4-b] diazepine-6 (11H)-ones", "year": "2013"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:tz746QTLzJkC", "citedby": "35"}, {"bib": {"title": "Discovery of a selective irreversible BMX inhibitor for prostate cancer", "year": "2013"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:Dem6FJhTUoYC", "citedby": "35"}, {"bib": {"title": "Dual blockade of lipid and cyclin-dependent kinases induces synthetic lethality in malignant glioma", "year": "2012"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:DUooU5lO8OsC", "citedby": "35"}, {"bib": {"title": "EWS/FLI confers tumor cell synthetic lethality to CDK12 inhibition in Ewing sarcoma", "year": "2018"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:boxvjr4fIrYC", "citedby": "34"}, {"bib": {"title": "BMK1 is involved in the regulation of p53 through disrupting the PML\u2013MDM2 interaction", "year": "2013"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:WJVC3Jt7v1AC", "citedby": "34"}, {"bib": {"title": "MELK is not necessary for the proliferation of basal-like breast cancer cells", "year": "2017"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:0J7bdoE8TH0C", "citedby": "33"}, {"bib": {"title": "DFG-out mode of inhibition by an irreversible type-1 inhibitor capable of overcoming gate-keeper mutations in FGF receptors", "year": "2015"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:uAPFzskPt0AC", "citedby": "33"}, {"bib": {"title": "Characterization of WZ4003 and HTH-01-015 as selective inhibitors of the LKB1-tumour-suppressor-activated NUAK kinases", "year": "2014"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:f8EKI0lD6ZEC", "citedby": "32"}, {"bib": {"title": "Drug discovery through industry-academic partnerships", "year": "2006"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:vV6vV6tmYwMC", "citedby": "32"}, {"bib": {"title": "Development of dual and selective degraders of cyclin\u2010dependent kinases 4 and 6", "year": "2019"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:9v9c93RoLYUC", "citedby": "31"}, {"bib": {"title": "Pyrimido-diazepinone kinase scaffold compounds and methods of treating disorders", "year": "2016"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:dQ2og3OwTAUC", "citedby": "31"}, {"bib": {"title": "Type II Raf kinase inhibitors", "year": "2015"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:fbc8zXXH2BUC", "citedby": "31"}, {"bib": {"title": "X-ray crystal structure of ERK5 (MAPK7) in complex with a specific inhibitor", "year": "2013"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:QyXJ3EUuO1IC", "citedby": "31"}, {"bib": {"title": "Discovery of 3, 5-diamino-1, 2, 4-triazole ureas as potent anaplastic lymphoma kinase inhibitors", "year": "2011"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:OU6Ihb5iCvQC", "citedby": "31"}, {"bib": {"title": "Modulation of TNF\u03b1, IL-10 and IL-12p40 levels by a ceramide-1-phosphate analog, PCERA-1, in vivo and ex vivo in primary macrophages", "year": "2009"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:f2IySw72cVMC", "citedby": "31"}, {"bib": {"title": "Purine inhibitors of protein kinases, G proteins and polymerases", "year": "2001"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:g5m5HwL7SMYC", "citedby": "31"}, {"bib": {"title": "Enhancer profiling identifies critical cancer genes and characterizes cell identity in adult T-cell leukemia", "year": "2017"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:0XvJNYv_SW4C", "citedby": "30"}, {"bib": {"title": "The mechanism of activation of IRAK1 and IRAK4 by interleukin-1 and Toll-like receptor agonists", "year": "2017"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:Bp_WFvcceWwC", "citedby": "30"}, {"bib": {"title": "A brain-penetrant RAF dimer antagonist for the noncanonical BRAF oncoprotein of pediatric low-grade astrocytomas", "year": "2017"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:dGK5M7Mi7LgC", "citedby": "30"}, {"bib": {"title": "c-Jun N-terminal kinase promotes stem cell phenotype in triple-negative breast cancer through upregulation of Notch1 via activation of c-Jun", "year": "2017"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:8m4wTQn51gQC", "citedby": "30"}, {"bib": {"title": "Discovery of a pyrrolopyrimidine (JH-II-127), a highly potent, selective, and brain penetrant LRRK2 inhibitor", "year": "2015"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:Nufq_to8ts0C", "citedby": "30"}, {"bib": {"title": "Small-molecule inhibitors of the c-Fes protein-tyrosine kinase", "year": "2012"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:bz8QjSJIRt4C", "citedby": "30"}, {"bib": {"title": "Compounds and compositions as protein kinase inhibitors", "year": "2010"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:SmHiq6L9e_wC", "citedby": "30"}, {"bib": {"title": "Vomocytosis of live pathogens from macrophages is regulated by the atypical MAP kinase ERK5", "year": "2017"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:ZJxCuUMT1foC", "citedby": "29"}, {"bib": {"title": "Development of Chemical Probes for Investigation of Salt-Inducible Kinase Function in Vivo", "year": "2016"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:zebm8Pw5eyMC", "citedby": "29"}, {"bib": {"title": "Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma", "year": "2018"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:1DepXQxl6QcC", "citedby": "28"}, {"bib": {"title": "Development of small molecules targeting the pseudokinase Her3", "year": "2015"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:zzCxg_vo7cAC", "citedby": "28"}, {"bib": {"title": "Development of ATP-competitive mTOR inhibitors", "year": "2012"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:geHnlv5EZngC", "citedby": "28"}, {"bib": {"title": "Microenvironmental influence on pre-clinical activity of polo-like kinase inhibition in multiple myeloma: implications for clinical translation", "year": "2011"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:BrmTIyaxlBUC", "citedby": "28"}, {"bib": {"title": "Discovery of a BTK/MNK dual inhibitor for lymphoma and leukemia", "year": "2016"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:AFXcoJnoRH0C", "citedby": "27"}, {"bib": {"title": "Discovery of inhibitors that overcome the G1202R anaplastic lymphoma kinase resistance mutation", "year": "2015"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:AY-FHVasAVwC", "citedby": "27"}, {"bib": {"title": "Targeted degradation of aberrant tau in frontotemporal dementia patient-derived neuronal cell models", "year": "2019"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:2LrnfYVLpIYC", "citedby": "26"}, {"bib": {"title": "Air spring stiffness controller", "year": "2005"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:23IbrMdp7nQC", "citedby": "26"}, {"bib": {"title": "Targeting MYC dependency in ovarian cancer through inhibition of CDK7 and CDK12/13", "year": "2018"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:AAUtRR4MQ9gC", "citedby": "25"}, {"bib": {"title": "ER stress signaling promotes the survival of cancer \u201cpersister cells\u201d tolerant to EGFR tyrosine kinase inhibitors", "year": "2018"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:vXJHGeUEVGkC", "citedby": "25"}, {"bib": {"title": "A UV-independent topical small-molecule approach for melanin production in human skin", "year": "2017"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:2K5qSjdd3awC", "citedby": "25"}, {"bib": {"title": "Ibrutinib targets mutant-EGFR kinase with a distinct binding conformation", "year": "2016"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:T3x1S4x-kFYC", "citedby": "25"}, {"bib": {"title": "Interleukin-6 secretion by astrocytes is dynamically regulated by PI3K-mTOR-calcium signaling", "year": "2014"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:J3LtWjKFLicC", "citedby": "25"}, {"bib": {"title": "Selective aurora kinase inhibitors identified using a taxol-induced checkpoint sensitivity screen", "year": "2012"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:7T2F9Uy0os0C", "citedby": "25"}, {"bib": {"title": "Compositions and methods for fgf receptor kinases inhibitors", "year": "2009"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:b0M2c_1WBrUC", "citedby": "25"}, {"bib": {"title": "Broad spectrum alkynyl inhibitors of T315I Bcr-Abl", "year": "2010"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:vRqMK49ujn8C", "citedby": "24"}, {"bib": {"title": "Methods for the synthesis of substituted purines", "year": "2005"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:Tiz5es2fbqcC", "citedby": "24"}, {"bib": {"title": "CDK12 loss in cancer cells affects DNA damage response genes through premature cleavage and polyadenylation", "year": "2019"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:xBbUbSzpRCkC", "citedby": "23"}, {"bib": {"title": "SRPKIN-1: A covalent SRPK1/2 Inhibitor that potently converts VEGF from pro-angiogenic to anti-angiogenic ISOFORM", "year": "2018"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:KH-Iy8IzxhYC", "citedby": "23"}, {"bib": {"title": "Characterization of DDR2 Inhibitors for the Treatment of DDR2 Mutated Nonsmall Cell Lung Cancer", "year": "2015"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:hKjooKYXoHIC", "citedby": "23"}, {"bib": {"title": "Ibrutinib selectively and irreversibly targets EGFR (L858R, Del19) mutant but is moderately resistant to EGFR (T790M) mutant NSCLC Cells", "year": "2015"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:GiYFt9mpioMC", "citedby": "23"}, {"bib": {"title": "Chemical proteomics identifies unanticipated targets of clinical kinase inhibitors", "year": "2007"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:rO6llkc54NcC", "citedby": "23"}, {"bib": {"title": "Methods of using chemical libraries to search for new kinase inhibitors", "year": "2003"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:BJbdYPG6LGMC", "citedby": "23"}, {"bib": {"title": "Single and dual targeting of mutant EGFR with an allosteric inhibitor", "year": "2019"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:GMpADU9lS7YC", "citedby": "22"}, {"bib": {"title": "Myeloid ERK5 deficiency suppresses tumor growth by blocking protumor macrophage polarization via STAT3 inhibition", "year": "2018"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:1werCE7_32MC", "citedby": "22"}, {"bib": {"title": "Overcoming resistance to the THZ series of covalent transcriptional CDK inhibitors", "year": "2018"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:z1mV0M3xdQ0C", "citedby": "22"}, {"bib": {"title": "Activation of the p53 transcriptional program sensitizes cancer cells to Cdk7 inhibitors", "year": "2017"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:CPlVwKnI7G4C", "citedby": "22"}, {"bib": {"title": "Erk5 is a key regulator of naive-primed transition and embryonic stem cell identity", "year": "2016"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:tL4NlYW7KOUC", "citedby": "22"}, {"bib": {"title": "GNF-2 inhibits dengue virus by targeting Abl kinases and the viral E protein", "year": "2016"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:A-tbffQ4IL8C", "citedby": "22"}, {"bib": {"title": "Chemical interrogation of the malaria kinome", "year": "2014"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:txeM2kYbVNMC", "citedby": "22"}, {"bib": {"title": "2, 4-pyrimidinediamines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders", "year": "2011"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:q6UlKCmR2LQC", "citedby": "22"}, {"bib": {"title": "Discovery of novel 1H-imidazol-2-yl-pyrimidine-4, 6-diamines as potential antimalarials", "year": "2010"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:abG-DnoFyZgC", "citedby": "22"}, {"bib": {"title": "Leveraging kinase inhibitors to develop small molecule tools for imaging kinases by fluorescence microscopy", "year": "2012"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:GtLg2Ama23sC", "citedby": "21"}, {"bib": {"title": "Methods and compositions as protein kinase inhibitors", "year": "2007"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:B3FOqHPlNUQC", "citedby": "21"}, {"bib": {"title": "BTKCys481Ser drives ibrutinib resistance via ERK1/2 and protects BTKwild-type MYD88-mutated cells by a paracrine mechanism", "year": "2018"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:BLjb4ZUULPkC", "citedby": "20"}, {"bib": {"title": "Development of highly potent and selective steroidal inhibitors and degraders of CDK8", "year": "2018"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:wkmAz21iQ3gC", "citedby": "20"}, {"bib": {"title": "Tuning microtubule dynamics to enhance cancer therapy by modulating FER-mediated CRMP2 phosphorylation", "year": "2018"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:kHL0TBcpPBcC", "citedby": "20"}, {"bib": {"title": "Inhibiting the oncogenic translation program is an effective therapeutic strategy in multiple myeloma", "year": "2017"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:FvdMn5VEULAC", "citedby": "20"}, {"bib": {"title": "Fused 2-aminothiazole compounds", "year": "2016"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:ojlX30-wUrgC", "citedby": "20"}, {"bib": {"title": "Extracellular signal\u2013regulated kinase 5 promotes acute cellular and systemic inflammation", "year": "2015"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:vxA22ZmNLkoC", "citedby": "20"}, {"bib": {"title": "Compounds and compositions as protein kinase inhibitors", "year": "2010"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:AXPGKjj_ei8C", "citedby": "20"}, {"bib": {"title": "Multifunction acoustic device", "year": "2003"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:LWqeokA2EBkC", "citedby": "20"}, {"bib": {"title": "Combinatorial libraries and biological discovery", "year": "2001"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:RYcK_YlVTxYC", "citedby": "20"}, {"bib": {"title": "High MITF expression is associated with super-enhancers and suppressed by CDK7 inhibition in melanoma", "year": "2018"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:fcpTrIVD8aEC", "citedby": "19"}, {"bib": {"title": "Type ii raf kinase inhibitors", "year": "2016"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:eqBG2gARfNgC", "citedby": "19"}, {"bib": {"title": "Soluble mTOR complexes and modulators thereof", "year": "2013"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:t6usbXjVLHcC", "citedby": "19"}, {"bib": {"title": "Beneficial effects of combining a type II ATP competitive inhibitor with an allosteric competitive inhibitor of BCR-ABL for the treatment of imatinib-sensitive and imatinib \u2026", "year": "2010"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:3s1wT3WcHBgC", "citedby": "19"}, {"bib": {"title": "Pharmacological enhancement of KCC2 gene expression exerts therapeutic effects on human Rett syndrome neurons and Mecp2 mutant mice", "year": "2019"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:eceui-4FXK0C", "citedby": "18"}, {"bib": {"title": "Inhibition of flaviviruses by targeting a conserved pocket on the viral envelope protein", "year": "2018"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:N8UqZ3HJrRYC", "citedby": "18"}, {"bib": {"title": "Identification and characterization of tyrosine kinase nonreceptor 2 mutations in leukemia through integration of kinase inhibitor screening and genomic analysis", "year": "2016"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:jNumyIlXk58C", "citedby": "18"}, {"bib": {"title": "Bruton tyrosine kinase degradation as a therapeutic strategy for cancer", "year": "2019"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:oNWKmzIW71IC", "citedby": "17"}, {"bib": {"title": "Small-molecule targeting of brachyury transcription factor addiction in chordoma", "year": "2019"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:3zsHChvjpfQC", "citedby": "17"}, {"bib": {"title": "Small-molecule studies identify CDK8 as a regulator of IL-10 in myeloid cells", "year": "2017"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:MBnQv3n-1h8C", "citedby": "17"}, {"bib": {"title": "Small-molecule inhibitors of LRRK2", "year": "2017"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:Ol96Buz8XVoC", "citedby": "17"}, {"bib": {"title": "Discovery of a highly potent and selective indenoindolone type 1 pan-FLT3 inhibitor", "year": "2016"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:jmj0Wi0nzAgC", "citedby": "17"}, {"bib": {"title": "Cell-based optimization of novel benzamides as potential antimalarial leads", "year": "2009"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:pyW8ca7W8N0C", "citedby": "17"}, {"bib": {"title": "Compositions and methods for inducing osteogenesis", "year": "2007"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:nWoA1JPTheMC", "citedby": "17"}, {"bib": {"title": "ERK5 is activated by oncogenic BRAF and promotes melanoma growth", "year": "2018"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:0U2LDkvwOo4C", "citedby": "16"}, {"bib": {"title": "Discoidin domain receptor 2 mediates collagen-induced activation of membrane-type 1 matrix metalloproteinase in human fibroblasts", "year": "2017"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:rmTuK8B1HbkC", "citedby": "16"}, {"bib": {"title": "A-770041 reverses paclitaxel and doxorubicin resistance in osteosarcoma cells", "year": "2014"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:qsWQJNntlusC", "citedby": "16"}, {"bib": {"title": "6-phenyl-7H-pyrrolo [2, 3-d] pyrimidine compounds that induce neuronal differentiation in embryonic stem cells", "year": "2007"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:XiSMed-E-HIC", "citedby": "16"}, {"bib": {"title": "Immunosuppressant compounds and compositions", "year": "2005"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:qfe1Ex3B87sC", "citedby": "16"}, {"bib": {"title": "Synthesis of chiral analogues of FTY720 and its phosphate", "year": "2003"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:NhqRSupF_l8C", "citedby": "16"}, {"bib": {"title": "A chemoproteomic strategy for direct and proteome-wide covalent inhibitor target-site identification", "year": "2018"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:viFR3AA6x-gC", "citedby": "15"}, {"bib": {"title": "Crystal structure of human IRAK1", "year": "2017"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:nf2iy15GSkQC", "citedby": "15"}, {"bib": {"title": "Hydrophobically tagged small molecules as inducers of protein degradation", "year": "2017"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:NZNkWSpQBv0C", "citedby": "15"}, {"bib": {"title": "Irreversible inhibition of BTK kinase by a novel highly selective inhibitor CHMFL-BTK-11 suppresses inflammatory response in rheumatoid arthritis model", "year": "2017"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:LqIPBQt8_ycC", "citedby": "15"}, {"bib": {"title": "Sustained Akt activity is required to maintain cell viability in seborrheic keratosis, a benign epithelial tumor", "year": "2016"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:jNf07s93Da0C", "citedby": "15"}, {"bib": {"title": "NVP\u2010TAE684 reverses multidrug resistance (MDR) in human osteosarcoma by inhibiting P\u2010glycoprotein (PGP1) function", "year": "2016"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:zSM0IxRRLoQC", "citedby": "15"}, {"bib": {"title": "Upregulation of IGF1R by mutant RAS in leukemia and potentiation of RAS signaling inhibitors by small-molecule inhibition of IGF1R", "year": "2014"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:V_vSwabWVtYC", "citedby": "15"}, {"bib": {"title": "Pharmacological inhibition of Eph receptors enhances glucose-stimulated insulin secretion from mouse and human pancreatic islets", "year": "2013"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:7BrZ7Jt4UNcC", "citedby": "15"}, {"bib": {"title": "Compounds and compositions useful for the treatment of malaria", "year": "2011"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:sSrBHYA8nusC", "citedby": "15"}, {"bib": {"title": "Discovery and characterization of novel mutant FLT3 kinase inhibitors", "year": "2010"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:SP6oXDckpogC", "citedby": "15"}, {"bib": {"title": "Bicyclic compounds and compositions", "year": "2007"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:08ZZubdj9fEC", "citedby": "15"}, {"bib": {"title": "Bis-aromatic alkanols", "year": "2007"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:vDijr-p_gm4C", "citedby": "15"}, {"bib": {"title": "BORIS promotes chromatin regulatory interactions in treatment-resistant cancer cells", "year": "2019"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:MwO77wwrKAAC", "citedby": "14"}, {"bib": {"title": "A high-throughput immune-oncology screen identifies EGFR inhibitors as potent enhancers of antigen-specific cytotoxic T-lymphocyte tumor cell killing", "year": "2018"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:GgEoN24wTPsC", "citedby": "14"}, {"bib": {"title": "KRAS G12C drug development: discrimination between switch II pocket configurations using hydrogen/deuterium-exchange mass spectrometry", "year": "2017"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:L8BhO0RnMU4C", "citedby": "14"}, {"bib": {"title": "Inactivation of KLF4 promotes T-cell acute lymphoblastic leukemia and activates the MAP2K7 pathway", "year": "2017"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:IQkZ9KeEy60C", "citedby": "14"}, {"bib": {"title": "Targeting Myddosome Assembly in Waldenstrom Macroglobulinaemia.", "year": "2017"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:yjYM2qeFg4IC", "citedby": "14"}, {"bib": {"title": "Inhibitors of c-Jun-N-terminal kinase (JNK)", "year": "2016"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:mUJArPsKIAAC", "citedby": "14"}, {"bib": {"title": "Protein Kinase Inhibitors and Methods for Using Thereof", "year": "2011"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:kzcrU_BdoSEC", "citedby": "14"}, {"bib": {"title": "Identification and characterization of small-molecule inducers of epidermal keratinocyte differentiation", "year": "2007"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:yD5IFk8b50cC", "citedby": "14"}, {"bib": {"title": "Development of a selective CDK7 covalent inhibitor reveals predominant cell-cycle phenotype", "year": "2019"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:OzVFaeRTpBgC", "citedby": "13"}, {"bib": {"title": "RAS\u2013MAPK reactivation facilitates acquired resistance in FGFR1-amplified lung cancer and underlies a rationale for upfront FGFR\u2013MEK blockade", "year": "2018"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:s3QjdzrrZf4C", "citedby": "13"}, {"bib": {"title": "Host targeted inhibitors of dengue virus and other viruses", "year": "2018"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:NU-BerS4NX4C", "citedby": "13"}, {"bib": {"title": "Discovery of a potent dual ALK and EGFR T790M inhibitor", "year": "2017"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:fD5pJnbkXkUC", "citedby": "13"}, {"bib": {"title": "Progress on covalent Inhibition of KRASG12C", "year": "2016"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:UsE54j44yzgC", "citedby": "13"}, {"bib": {"title": "Targeting IRAK1/IRAK4 signaling in Waldenstrom's Macroglobulinemia", "year": "2015"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:jQdzyB-Dl8gC", "citedby": "13"}, {"bib": {"title": "SnapShot: kinase inhibitors II", "year": "2015"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:gmHTDCtJMcoC", "citedby": "13"}, {"bib": {"title": "Identification of novel small molecule inhibitors of oncogenic RET kinase", "year": "2015"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:VnuxuLaQPLMC", "citedby": "13"}, {"bib": {"title": "Fluorescent visualization of Src by using dasatinib\u2010BODIPY", "year": "2014"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:3lUAU8Oskd0C", "citedby": "13"}, {"bib": {"title": "Discovery of Allosteric Bcr\u2013Abl Inhibitors from Phenotypic Screen to Clinical Candidate", "year": "2014"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:PVqtIyvKoSUC", "citedby": "13"}, {"bib": {"title": "PI3K/AKT pathway is activated by MYD88 L265P and use of PI3K-delta inhibitors induces robust tumor cell killing in Waldenstrom\u2019s Macroglobulinemia", "year": "2013"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:WWeOtg8bX_EC", "citedby": "13"}, {"bib": {"title": "Substituted pyrrolo [2, 3-d] pyrimidines and compositions as protein kinase inhibitors", "year": "2012"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:VLnqNzywnoUC", "citedby": "13"}, {"bib": {"title": "Cyclic compounds and compositions as protein kinase inhibitors", "year": "2006"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:eMMeJKvmdy0C", "citedby": "13"}, {"bib": {"title": "Gemcitabine and Chk1 inhibitor AZD7762 synergistically suppress the growth of Lkb1-deficient lung adenocarcinoma", "year": "2017"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:OeO3PiPA3c0C", "citedby": "12"}, {"bib": {"title": "Structure-guided development of covalent TAK1 inhibitors", "year": "2017"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:CWT8puhM_EkC", "citedby": "12"}, {"bib": {"title": "Identification of novel therapeutic targets in acute leukemias with NRAS mutations using a pharmacologic approach", "year": "2015"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:oYLFIHfuHKwC", "citedby": "12"}, {"bib": {"title": "Small molecule myristate inhibitors of BCR-ABL and methods of use", "year": "2014"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:_B80troHkn4C", "citedby": "12"}, {"bib": {"title": "An amino-indazole scaffold with spectrum selective kinase inhibition of FLT3, PDGFR\u03b1 and kit", "year": "2012"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:FAceZFleit8C", "citedby": "12"}, {"bib": {"title": "Selective ATP-Competitive Inhibitors of TOR Suppress Rapamycin-Insensitive Function of TORC2 in Saccharomyces cerevisiae", "year": "2012"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:Ri6SYOTghG4C", "citedby": "12"}, {"bib": {"title": "Small molecule degraders of the hepatitis C virus protease reduce susceptibility to resistance mutations", "year": "2019"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:ePvl-qvmuzUC", "citedby": "11"}, {"bib": {"title": "Specific covalent inhibition of MALT1 paracaspase suppresses B cell lymphoma growth", "year": "2018"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:bIWuQ2t9ofkC", "citedby": "11"}, {"bib": {"title": "When kinases meet PROTACs", "year": "2018"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:c0PuCX1G1FcC", "citedby": "11"}, {"bib": {"title": "Structural and atropisomeric factors governing the selectivity of pyrimido-benzodiazipinones as inhibitors of kinases and bromodomains", "year": "2018"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:G9wvEplfBxAC", "citedby": "11"}, {"bib": {"title": "Discovery and optimization of potent and selective benzonaphthyridinone analogs as small molecule mTOR inhibitors with improved mouse microsome stability", "year": "2011"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:LI9QrySNdTsC", "citedby": "11"}, {"bib": {"title": "\u201cGoing KiNativ\u201d: probing the native kinome", "year": "2011"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:kuK5TVdYjLIC", "citedby": "11"}, {"bib": {"title": "5-Substituted Thiazol-2-Yl Amino Compounds and Compositions as Protein Kinase Inhibitors", "year": "2008"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:uWQEDVKXjbEC", "citedby": "11"}, {"bib": {"title": "Cheminformatics tools for analyzing and designing optimized Small-Molecule collections and libraries", "year": "2019"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:MGzV0Qdvj_oC", "citedby": "10"}, {"bib": {"title": "Synergistic interactions with PI3K inhibition that induce apoptosis", "year": "2017"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:WbmfLAu0znQC", "citedby": "10"}, {"bib": {"title": "Discovery of host-targeted covalent inhibitors of dengue virus", "year": "2017"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:J9pY9yJF5awC", "citedby": "10"}, {"bib": {"title": "Discovery of a highly selective STK16 kinase inhibitor", "year": "2016"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:18U4RWrXZp4C", "citedby": "10"}, {"bib": {"title": "Inhibition of IKK\u03b1 by BAY61-3606 reveals IKK\u03b1-dependent histone H3 phosphorylation in human cytomegalovirus infected cells", "year": "2016"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:XptqmJ6C52sC", "citedby": "10"}, {"bib": {"title": "Fused 2-aminothiazole compounds", "year": "2014"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:kh2fBNsKQNwC", "citedby": "10"}, {"bib": {"title": "Pyrimidine-substituted benzimidazole derivatives as protein kinase inhibitors", "year": "2013"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:r_AWSJRzSzQC", "citedby": "10"}, {"bib": {"title": "BAY61-3606 affects the viability of colon cancer cells in a genotype-directed manner", "year": "2012"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:6ZxmRoH8BuwC", "citedby": "10"}, {"bib": {"title": "CDK7 inhibition potentiates genome instability triggering anti-tumor immunity in small cell lung cancer", "year": "2020"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:zQ-Gyk3yozYC", "citedby": "9"}, {"bib": {"title": "Structural complementarity facilitates E7820-mediated degradation of RBM39 by DCAF15", "year": "2020"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:LPThKXBVh8AC", "citedby": "9"}, {"bib": {"title": "Leveraging compound promiscuity to identify targetable cysteines within the kinome", "year": "2019"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:Jw3o-D-4QLAC", "citedby": "9"}, {"bib": {"title": "SIK inhibitor for use in a method of treating an inflammatory and/or immune disorder", "year": "2017"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:T8_be82Iz5gC", "citedby": "9"}, {"bib": {"title": "Identification of compounds with anti-human cytomegalovirus activity that inhibit production of IE2 proteins", "year": "2017"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:kWRwubw1DjEC", "citedby": "9"}, {"bib": {"title": "A benzo[b]thiophene-based selective type 4 S1P receptor agonist", "year": "2017"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:uwB3iyG56gEC", "citedby": "9"}, {"bib": {"title": "Dual inhibition of Fes and Flt3 tyrosine kinases potently inhibits Flt3-ITD+ AML cell growth", "year": "2017"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:rI7N8NGxj9wC", "citedby": "9"}, {"bib": {"title": "Leveraging gas-phase fragmentation pathways for improved identification and selective detection of targets modified by covalent probes", "year": "2016"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:41KyI4NE9qkC", "citedby": "9"}, {"bib": {"title": "Type II RAF kinase inhibitors", "year": "2016"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:-gKCQx66J1MC", "citedby": "9"}, {"bib": {"title": "Hematopoietic androgen receptor deficiency promotes visceral fat deposition in male mice without impairing glucose homeostasis", "year": "2015"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:TR6-gCkegYUC", "citedby": "9"}, {"bib": {"title": "Soluble mTOR complexes and modulators thereof", "year": "2014"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:WVyJMqqT78IC", "citedby": "9"}, {"bib": {"title": "300 Preclinical pharmacologic characterization of GSK2849330, a monoclonal AccretaMab\u00ae antibody with optimized ADCC and CDC activity directed against HER3", "year": "2014"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:G36d5HCDkJYC", "citedby": "9"}, {"bib": {"title": "Compounds and Compositions as Inhibitors of Receptor Tyrosine Kinase Activity", "year": "2011"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:LRFP056OPQYC", "citedby": "9"}, {"bib": {"title": "ZUSCHRIFTEN-Discovery of Carbohydrate Sulfotransferase Inhibitors from a Kinase-Directed Library", "year": "2000"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:8dk-3UP3FqQC", "citedby": "9"}, {"bib": {"title": "Structure\u2013Activity Relationship Study of QL47: A Broad-Spectrum Antiviral Agent", "year": "2017"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:xmdbLjM3F_sC", "citedby": "8"}, {"bib": {"title": "Studies of TAK1-centered polypharmacology with novel covalent TAK1 inhibitors", "year": "2017"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:QcA0cUGko98C", "citedby": "8"}, {"bib": {"title": "Uses of diazepane derivatives", "year": "2017"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:iwrO-dAzKaMC", "citedby": "8"}, {"bib": {"title": "Discovery of a Series of 5,11-Dihydro-6H-benzo[e]pyrimido[5,4-b][1,4]diazepin-6-ones as Selective PI3K-\u03b4/\u03b3 Inhibitors", "year": "2016"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:a9QG1FYusaQC", "citedby": "8"}, {"bib": {"title": "Pathophysiological significance and therapeutic targeting of germinal center kinase in diffuse large B-cell lymphoma", "year": "2016"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:5Hj2J4YjVXQC", "citedby": "8"}, {"bib": {"title": "Indazole compounds and their uses", "year": "2015"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:-jrNzM816MMC", "citedby": "8"}, {"bib": {"title": "Discovery of pyrimidine benzimidazoles as Src-family selective Lck inhibitors. Part II", "year": "2009"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:tOudhMTPpwUC", "citedby": "8"}, {"bib": {"title": "Composite yarns and moisture management fabrics made therefrom", "year": "2003"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:K7YvBqpTqvwC", "citedby": "8"}, {"bib": {"title": "Discovery of a highly potent and broadly effective epidermal growth factor receptor and HER2 exon 20 insertion mutant inhibitor", "year": "2018"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:DlO-8NBk_-wC", "citedby": "7"}, {"bib": {"title": "Discovery of immunologically inspired small molecules that target the viral envelope protein", "year": "2018"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:23OMmoBQBk8C", "citedby": "7"}, {"bib": {"title": "Selective Inhibition of the Myeloid Src-Family Kinase Fgr Potently Suppresses AML Cell Growth in Vitro and in Vivo", "year": "2018"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:dWFDXTerv58C", "citedby": "7"}, {"bib": {"title": "Structure-activity relationship investigation for benzonaphthyridinone derivatives as novel potent Bruton's tyrosine kinase (BTK) irreversible inhibitors", "year": "2017"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:TjyTfcaXIY8C", "citedby": "7"}, {"bib": {"title": "Diazepane derivatives and uses thereof", "year": "2017"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:paYMmCCHv7cC", "citedby": "7"}, {"bib": {"title": "Torin2 suppresses ionizing radiation-induced DNA damage repair", "year": "2016"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:8Wqc2CfJRaAC", "citedby": "7"}, {"bib": {"title": "Ras inhibitors and uses thereof", "year": "2016"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:6DAfjB2iXzsC", "citedby": "7"}, {"bib": {"title": "A Discovery Strategy for Selective Inhibitors of c\u2010Src in Complex with the Focal Adhesion Kinase SH3/SH2\u2010binding Region", "year": "2015"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:DQNrXyjhriIC", "citedby": "7"}, {"bib": {"title": "Protein Kinase Inhibitors and Methods for Using Thereof", "year": "2010"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:JP7YXuLIOvAC", "citedby": "7"}, {"bib": {"title": "A quantitative tissue-specific landscape of protein redox regulation during aging", "year": "2020"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:qdVtQq3Eg_YC", "citedby": "6"}, {"bib": {"title": "A multitargeted probe-based strategy to identify signaling vulnerabilities in cancers", "year": "2019"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:Ec25XKZgu8sC", "citedby": "6"}, {"bib": {"title": "BCL2 amplicon loss and transcriptional remodeling drives ABT-199 resistance in B cell lymphoma models", "year": "2019"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:KDIJNi6oDIIC", "citedby": "6"}, {"bib": {"title": "How small-molecule inhibitors of dengue-virus infection interfere with viral membrane fusion", "year": "2018"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:-dO1ppr5CRQC", "citedby": "6"}, {"bib": {"title": "Hydrophobically tagged janus kinase inhibitors and uses thereof", "year": "2018"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:d1QmopYJ1igC", "citedby": "6"}, {"bib": {"title": "Kinase inhibitors for the treatment of disease", "year": "2017"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:yd8rdvfCKnwC", "citedby": "6"}, {"bib": {"title": "HCK Is a Highly Relevant Target of Ibrutinib in MYD88 Mutated Waldenstrom's Macroglobulinemia and Diffuse Large B-Cell Lymphoma", "year": "2015"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:z-xpeKpFZ3wC", "citedby": "6"}, {"bib": {"title": "Suppression of interferon \u03b2 gene transcription by inhibitors of bromodomain and extra-terminal (BET) family members", "year": "2015"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:BBcCmHsDWsAC", "citedby": "6"}, {"bib": {"title": "Novel EGFR mutations that cause drug resistance to irreversible pyrimidine but not quinazoline based EGFR inhibitors", "year": "2012"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:M_lZXyI38BkC", "citedby": "6"}, {"bib": {"title": "The S1P1/S1P5 receptor modulator BAF312 reverses neurological deficits in ongoing EAE, reduces specific lymphocyte subsets in healthy volunteers and is a potential new multiple \u2026", "year": "2009"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:BrOSOlqYqPUC", "citedby": "6"}, {"bib": {"title": "Sensory neuron receptors", "year": "2003"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:1lhNe0rCu4AC", "citedby": "6"}, {"bib": {"title": "Motor vehicle with an automated torque-transfer system", "year": "2003"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:SKbDCQBpHTkC", "citedby": "6"}, {"bib": {"title": "Methods to treat lymphoplasmacytic lymphoma", "year": "2018"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:rqo51bwTRb4C", "citedby": "5"}, {"bib": {"title": "Methods to treat lymphoplasmacytic lymphoma", "year": "2018"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:KEmvaKc6tCQC", "citedby": "5"}, {"bib": {"title": "A novel, highly selective IRAK1 inhibitor Jh-X-119-01 shows synergistic tumor cell killing with ibrutinib in MYD88 mutated B-cell lymphoma cells", "year": "2017"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:7LH0YzRCML8C", "citedby": "5"}, {"bib": {"title": "Protein kinase inhibitors", "year": "2013"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:6_hjMsCP8ZoC", "citedby": "5"}, {"bib": {"title": "Development of \u2018DFG-out\u2019inhibitors of gatekeeper mutant kinases", "year": "2012"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:NXb4pA-qfm4C", "citedby": "5"}, {"bib": {"title": "Compositions and methods for treating cancers", "year": "2011"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:VL0QpB8kHFEC", "citedby": "5"}, {"bib": {"title": "Acquired resistance to MET kinase inhibition in MET-dependent non-small cell lung cancer cells mediated by a switch to EGFR dependency", "year": "2010"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:tzM49s52ZIMC", "citedby": "5"}, {"bib": {"title": "Compounds and compositions as protein kinase inhibitors", "year": "2009"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:nqaVwkbM98IC", "citedby": "5"}, {"bib": {"title": "Exploring Targeted Degradation Strategy for Oncogenic KRASG12C", "year": "2020"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:eO2F4e7mqQkC", "citedby": "4"}, {"bib": {"title": "Discovery of an AKT Degrader with Prolonged Inhibition of Downstream Signaling", "year": "2020"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:rDC_CG-fcEMC", "citedby": "4"}, {"bib": {"title": "Development and Characterization of a Wee1 Kinase Degrader", "year": "2020"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:1desnc-wk2oC", "citedby": "4"}, {"bib": {"title": "Comparison of effects of midostaurin, crenolanib, quizartinib, gilteritinib, sorafenib and BLU\u2010285 on oncogenic mutants of KIT, CBL and FLT3 in haematological malignancies", "year": "2019"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:dR4LSGKtw-IC", "citedby": "4"}, {"bib": {"title": "Recent Advances in Selective and Irreversible Covalent Ligand Development and Validation", "year": "2019"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:aT2_oyLf33AC", "citedby": "4"}, {"bib": {"title": "Novel scaffolds for Dual specificity tyrosine-phosphorylation-regulated kinase (DYRK1A) inhibitors", "year": "2018"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:2253VHV31tMC", "citedby": "4"}, {"bib": {"title": "Uses of salt-inducible kinase (sik) inhibitors", "year": "2017"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:RcYKfjg9Zh4C", "citedby": "4"}, {"bib": {"title": "Pyrimido-diazepinone compounds and methods of treating disorders", "year": "2017"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:YynyIpEqGK0C", "citedby": "4"}, {"bib": {"title": "Protected amine labels: a versatile molecular scaffold for multiplexed nominal mass and sub-Da isotopologue quantitative proteomic reagents", "year": "2014"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:lbI08cpqPnQC", "citedby": "4"}, {"bib": {"title": "High-molecular weight polymers and methods of manufacture", "year": "2004"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:IzSxq8zsU60C", "citedby": "4"}, {"bib": {"title": "Treatment-induced tumor dormancy through YAP-mediated transcriptional reprogramming of the apoptotic pathway", "year": "2020"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:Cjb_BMXg7WwC", "citedby": "3"}, {"bib": {"title": "HCK as a therapeutic target in MYD88 mutated diseases", "year": "2020"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:tC_cyO4PokcC", "citedby": "3"}, {"bib": {"title": "Discovery and Optimization of Dibenzodiazepinones as Allosteric Mutant-Selective EGFR Inhibitors", "year": "2019"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:ysAkk8fzSpoC", "citedby": "3"}, {"bib": {"title": "What it takes to improve a first-generation inhibitor to a second-or third-generation small molecule", "year": "2019"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:pmpdM2zT1M8C", "citedby": "3"}, {"bib": {"title": "JNK2 Is Required for the Tumorigenic Properties of Melanoma Cells", "year": "2019"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:I9VVr87FQe4C", "citedby": "3"}, {"bib": {"title": "Identification of small molecule inhibitors targeting the Zika virus envelope protein", "year": "2019"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:UI5LpD2ufboC", "citedby": "3"}, {"bib": {"title": "Small Molecules Targeting the Flavivirus E Protein with Broad-Spectrum Activity and Antiviral Efficacy in Vivo", "year": "2019"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:3LFXdIMtrAwC", "citedby": "3"}, {"bib": {"title": "Thiazolyl-containing compounds for treating proliferative diseases", "year": "2018"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:f0OD9WVUAbYC", "citedby": "3"}, {"bib": {"title": "Targeting the extracellular signal-regulated kinase 5 pathway to suppress human chronic myeloid leukemia stem cells", "year": "2018"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:jT7pUvmeQrMC", "citedby": "3"}, {"bib": {"title": "BMX-mediated regulation of multiple tyrosine kinases contributes to castration resistance in prostate cancer", "year": "2018"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:QWeA35B1DCcC", "citedby": "3"}, {"bib": {"title": "Polycyclic inhibitors of cyclin-dependent kinase 7 (CDK7)", "year": "2018"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:RTnHyEp0C-wC", "citedby": "3"}, {"bib": {"title": "Correction: MELK is an oncogenic kinase essential for mitotic progression in basal-like breast cancer cells", "year": "2018"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:-U72JhJFxmcC", "citedby": "3"}, {"bib": {"title": "Characterization of a highly selective inhibitor of the Aurora kinases", "year": "2017"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:iRVS5cWFCuIC", "citedby": "3"}, {"bib": {"title": "Small Molecule Inhibitors of ALK", "year": "2017"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:9ozBiMEOI0QC", "citedby": "3"}, {"bib": {"title": "Heteroaromatic compounds useful for the treatment of prolferative diseases", "year": "2016"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:QhyW1pcpMSYC", "citedby": "3"}, {"bib": {"title": "Abstract B165: Optimizing selective CDK7 inhibition in MYCN-driven neuroblastoma", "year": "2015"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:TaF7eNGHiZkC", "citedby": "3"}, {"bib": {"title": "Twenty high-grade traditional Chinese medicines: Their anti-HIV, antibacterial, and anticancer biological screening.", "year": "2005"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:O0nohqN1r9EC", "citedby": "3"}, {"bib": {"title": "Methods of using chemical libraries to search for new kinase inhibitors", "year": "2003"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:PGOTqER0XmoC", "citedby": "3"}, {"bib": {"title": "Method for producing a three-dimensional object which can be tactilely sensed, and the resultant object", "year": "2003"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:O4XjznA6cfkC", "citedby": "3"}, {"bib": {"title": "Methods to treat lymphoplasmacytic lymphoma", "year": "2020"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:hzzPUFEODy8C", "citedby": "2"}, {"bib": {"title": "Targeting the PI5P4K Lipid Kinase Family in Cancer Using Covalent Inhibitors", "year": "2020"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:zVSo-THGCDcC", "citedby": "2"}, {"bib": {"title": "Torin2 exploits replication and checkpoint vulnerabilities to cause death of PI3K-activated triple-negative breast cancer cells", "year": "2020"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:vgb0g4rEShEC", "citedby": "2"}, {"bib": {"title": "Thiazolyl-containing compounds for treating proliferative diseases", "year": "2019"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:YMqph-EB6eoC", "citedby": "2"}, {"bib": {"title": "Structure\u2013Activity Relationship Study of Covalent Pan-phosphatidylinositol 5-Phosphate 4-Kinase Inhibitors", "year": "2019"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:0yVh_IzAmHcC", "citedby": "2"}, {"bib": {"title": "Bifunctional molecules for degradation of EGFR and methods of use", "year": "2019"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:97OsqvYTX2EC", "citedby": "2"}, {"bib": {"title": "Quinoline and thiazolopyridine allosteric inhibitors of MALT1", "year": "2019"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:pTM1p95iyDUC", "citedby": "2"}, {"bib": {"title": "Discovery of Covalent CDK14 Inhibitors with Pan-TAIRE Family Specificity", "year": "2019"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:LOUAI8Maf04C", "citedby": "2"}, {"bib": {"title": "Peptide-based covalent inhibitors of MALT1 paracaspase", "year": "2019"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:Llf8zd38bwoC", "citedby": "2"}, {"bib": {"title": "Bifunctional compounds for her3 degradation and methods of use", "year": "2019"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:h0bj9BThk1MC", "citedby": "2"}, {"bib": {"title": "Inhibitors of cyclin-dependent kinases", "year": "2018"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:1TSF5MOUvycC", "citedby": "2"}, {"bib": {"title": "Combination therapy of transcription inhibitors and kinase inhibitors", "year": "2018"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:RUJ4dIkaTBcC", "citedby": "2"}, {"bib": {"title": "It Takes Two To Target: A Study in KRAS Dimerization", "year": "2018"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:tfFR5hCbSrAC", "citedby": "2"}, {"bib": {"title": "Erratum: Corrigendum: SIKs control osteocyte responses to parathyroid hormone", "year": "2017"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:xiLpnPg9mi8C", "citedby": "2"}, {"bib": {"title": "Correction to Discovery of a Potent and Selective DDR1 Receptor Tyrosine Kinase Inhibitor", "year": "2014"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:6ZzL7HXColQC", "citedby": "2"}, {"bib": {"title": "Dissection of Bcr-abl Structural Domains Relating to Kinase Auto-Inhibition Using a Forward Mutational Screen with the Non-ATP Competitive Inhibitor GNF-2.", "year": "2007"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:738O_yMBCRsC", "citedby": "2"}, {"bib": {"title": "Pyrimidine urea derivatives as kinase inhibitors", "year": "2006"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:epqYDVWIO7EC", "citedby": "2"}, {"bib": {"title": "Dynamic unbalance compensation system and method", "year": "2004"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:pLhbkOKWazAC", "citedby": "2"}, {"bib": {"title": "Allosteric Activators of Protein Phosphatase 2A Display Broad Antitumor Activity Mediated by Dephosphorylation of MYBL2", "year": "2020"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:y8M7zB61foAC", "citedby": "1"}, {"bib": {"title": "Discovery of a selective inhibitor of doublecortin like kinase 1", "year": "2020"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:3Ug0zW_GgLgC", "citedby": "1"}, {"bib": {"title": "Inhibition of the deubiquitinase USP10 induces degradation of SYK", "year": "2020"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:eLuibZyXBAwC", "citedby": "1"}, {"bib": {"title": "Effects of the multi\u2010kinase inhibitor midostaurin in combination with chemotherapy in models of acute myeloid leukaemia", "year": "2020"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:wemvFa-GEFIC", "citedby": "1"}, {"bib": {"title": "Salt-inducible kinase 1 maintains HDAC7 stability to promote pathologic cardiac remodeling", "year": "2020"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:99Pv1cn5vGAC", "citedby": "1"}, {"bib": {"title": "Light-induced control of protein destruction by opto-PROTAC", "year": "2020"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:veuxFd29oYUC", "citedby": "1"}, {"bib": {"title": "Evaluation of ERK as a therapeutic target in acute myelogenous leukemia", "year": "2020"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:EiA1hA_4fYQC", "citedby": "1"}, {"bib": {"title": "SYK is activated by mutated MYD88 and drives pro-survival signaling in MYD88 driven B-cell lymphomas", "year": "2020"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:iJ9CcAdTEy0C", "citedby": "1"}, {"bib": {"title": "Bone marrow on x chromosome kinase (bmx) inhibitors and uses thereof", "year": "2020"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:Pd6fkz2DsnkC", "citedby": "1"}, {"bib": {"title": "Inhibitors of cyclin-dependent kinase 7 (cdk7)", "year": "2020"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:JCGcFKGLtV4C", "citedby": "1"}, {"bib": {"title": "Structure-based design of a potent and selective covalent inhibitor for SRC kinase that targets a p-Loop cysteine", "year": "2020"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:zh6eSHzbrgQC", "citedby": "1"}, {"bib": {"title": "STRIPAK directs PP2A activity toward MAP4K4 to promote oncogenic transformation of human cells", "year": "2020"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:IrNVrO9MNnIC", "citedby": "1"}, {"bib": {"title": "A Novel HCK and BTK Dual Inhibitor Kin-8194 Shows Superior Activity over Ibrutinib and Overcomes BTKC481S Mediated Ibrutinib Resistance in Vitro and In Vivo in MYD88 Mutated B \u2026", "year": "2019"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:Vf1ZiD7uWLsC", "citedby": "1"}, {"bib": {"title": "A kinase-independent role for CDK8 in BCR-ABL1+ leukemia", "year": "2019"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:iI4frfBhC7MC", "citedby": "1"}, {"bib": {"title": "Dual Inhibition of TAF1 and BET Bromodomains from the BI-2536 Kinase Inhibitor Scaffold", "year": "2019"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:_Ib3u7pdcXQC", "citedby": "1"}, {"bib": {"title": "Coordinating Tissue Regeneration Through Transforming Growth Factor\u2010\u03b2 Activated Kinase 1 Inactivation and Reactivation", "year": "2019"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:x_nEMsjMe4QC", "citedby": "1"}, {"bib": {"title": "Uses of salt-inducible kinase (SIK) inhibitors", "year": "2019"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:i2WBo1Z0jAEC", "citedby": "1"}, {"bib": {"title": "Degradation of cyclin-dependent kinase 8 (cdk8) by conjugation of cdk8 inhibitors with e3 ligase ligand and methods of use", "year": "2019"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:wvdErfMaJJYC", "citedby": "1"}, {"bib": {"title": "Degradation of cyclin-dependent kinase 4/6 (cdk4/6) by conjugation of cdk4/6 inhibitors with e3 ligase ligand and methods of use", "year": "2019"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:5LPpnTyo_ycC", "citedby": "1"}, {"bib": {"title": "Conformational flexibility and inhibitor binding to unphosphorylated interleukin-1 receptor\u2013associated kinase 4 (IRAK4)", "year": "2019"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:GU7uRbhnQ_0C", "citedby": "1"}, {"bib": {"title": "Inhibitors of cyclindependent kinase 7 (cdk7)", "year": "2019"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:Uq2dEd23X6oC", "citedby": "1"}, {"bib": {"title": "Polycyclic inhibitors of cyclin-dependent kinase 7 (cdk7)", "year": "2019"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:mtdGyXoswmMC", "citedby": "1"}, {"bib": {"title": "Pyrimido-diazepinone compounds and methods of treating disorders", "year": "2019"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:XVBKMArtY_gC", "citedby": "1"}, {"bib": {"title": "Substituted heterocyclic compounds for treating or preventing viral infections", "year": "2018"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:EHjGVGKDnHoC", "citedby": "1"}, {"bib": {"title": "Inhibitors of c-Jun-N-terminal kinase (JNK)", "year": "2018"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:qtIad817JNcC", "citedby": "1"}, {"bib": {"title": "MYD88 triggered SYK activation promotes BCR cross-talk, and identifies SYK as a novel therapeutic target of mutated MYD88 signaling", "year": "2018"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:hnLuywnv79wC", "citedby": "1"}, {"bib": {"title": "First SAR Study for Overriding NRAS Mutant Driven Acute Myeloid Leukemia", "year": "2018"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:aPC4W50LcyUC", "citedby": "1"}, {"bib": {"title": "Hydrophobically tagged small molecules as inducers of protein degradation", "year": "2018"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:ptKmfjyPmtwC", "citedby": "1"}, {"bib": {"title": "Cheminformatics tools for analyzing and designing optimized small molecule libraries", "year": "2018"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:BxOedqCeNo0C", "citedby": "1"}, {"bib": {"title": "Spatio-Temporal Analyses of Pesticide Use on Walnuts and Potential Risks to Surface Water in California", "year": "2018"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:0ZEOuji6PikC", "citedby": "1"}, {"bib": {"title": "Compounds and methods for treating cancer", "year": "2017"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:C75MlVM-XVcC", "citedby": "1"}, {"bib": {"title": "A simple method to identify kinases that regulate embryonic stem cell pluripotency by high-throughput inhibitor screening", "year": "2017"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:c9MN4jr3zw0C", "citedby": "1"}, {"bib": {"title": "SIKs control osteocyte responses to parathyroid hormone (vol 7, 13176, 2017)", "year": "2017"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:vQNBHXYRXdUC", "citedby": "1"}, {"bib": {"title": "GTP-Competitive Inhibitors of RAS Family Members", "year": "2017"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:YzaYdgFdL8IC", "citedby": "1"}, {"bib": {"title": "Inhibition of USP10 Induces Degradation of Oncogenic FLT3: a novel approach to therapy of leukemia", "year": "2016"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:OShvA0zO5LQC", "citedby": "1"}, {"bib": {"title": "CDK12/13 inhibition cooperates with the Ewing sarcoma oncoprotein EWS/FLI to attenuate homologous recombination repair in Ewing sarcoma cells", "year": "2016"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:Ioyf5y7uRMMC", "citedby": "1"}, {"bib": {"title": "Suppression of triple-negative breast cancer tumorigenesis by targeting cancer stem cells through JNK/Notch1 signaling inhibition", "year": "2015"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:5LPo_wSKItgC", "citedby": "1"}, {"bib": {"title": "Erratum to Targeting transcriptional addictions in small cell lung cancer with a covalent CDK7 inhibitor [Cancer Cell 26,(2014) 909-922]", "year": "2015"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:NNPL2XyPKO8C", "citedby": "1"}, {"bib": {"title": "Serine/threonine kinase STK4 is a novel target in myeloma", "year": "2014"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:wBLCggQE-ToC", "citedby": "1"}, {"bib": {"title": "Transcription Regulation Targeting in Peripheral T Cell Lymphomas Induces Apoptosis and Sensitization to BCL2 Inhibitors", "year": "2014"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:cB__R-XWw9UC", "citedby": "1"}, {"bib": {"title": "Genetic and pharmacologic inhibition of EPHA2 promotes apoptosis in NSCLC", "year": "2014"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:ybo9GWVbjlMC", "citedby": "1"}, {"bib": {"title": "Chemical biology for target identification and validation", "year": "2014"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:zOZn3-bHan0C", "citedby": "1"}, {"bib": {"title": "Compounds that modulate EGFR activity and methods for treating or preventing conditions therewith", "year": "2013"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:-lDlBIcJJzsC", "citedby": "1"}, {"bib": {"title": "MEDI 339-Cell-based optimization of novel benzamides as antimalarials", "year": "2008"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:-nhnvRiOwuoC", "citedby": "1"}, {"bib": {"title": "EML4-ALK fusion gene and sensitivity to an ALK kinase inhibitor in lung cancer", "year": "2008"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:wGzT3bKASkAC", "citedby": "1"}, {"bib": {"title": "Small molecule inhibitors: Design and selection", "year": "2007"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:wbdj-CoPYUoC", "citedby": "1"}, {"bib": {"title": "Serial communication circuit and serial transmitting and receiving system", "year": "2003"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:jsRXtjpS08UC", "citedby": "1"}, {"bib": {"title": "Chemical tools for functional genomics.", "year": "2001"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:Y9VhQm-5nPIC", "citedby": "1"}, {"bib": {"title": "A chemistry-based approach to identify regulators of spindle assembly: Characterization of a microtubule destabilizing compound and target identification.", "year": "2000"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:w1MjKQ0l0TYC", "citedby": "1"}, {"bib": {"title": "Synthesis and biological application of 2, 6, 9-trisubstituted purine libraries", "year": "1999"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:8AbLer7MMksC", "citedby": "1"}, {"bib": {"title": "Development of CDK2 and CDK5 Dual Degrader TMX\u20102172", "year": "2020"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:xrERVq8-JpsC", "citedby": "0"}, {"bib": {"title": "CDK13 cooperates with CDK12 to control global RNA polymerase II processivity", "year": "2020"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:Vc_znlpJgV8C", "citedby": "0"}, {"bib": {"title": "Tubulin Resists Degradation by Cereblon-Recruiting PROTACs", "year": "2020"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:0dL35dZyZCwC", "citedby": "0"}, {"bib": {"title": "Discovery and Structure-Activity Relationship Study of (Z)-5-Methylenethiazolidin-4-one Derivatives as Potent and Selective Pan-phosphatidylinositol 5-Phosphate 4-Kinase Inhibitors", "year": "2020"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:PffFD9Wx8kQC", "citedby": "0"}, {"bib": {"title": "A Rationally Designed Covalent BCL6 Inhibitor that Targets a Ty-rosine Residue in the Homodimer Interface", "year": "2020"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:EYm_cm7jVOkC", "citedby": "0"}, {"bib": {"title": "Bifunctional molecules for degradation of egfr and methods of use", "year": "2020"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:53tJ1FdZAwMC", "citedby": "0"}, {"bib": {"title": "Defining and targeting adaptations to oncogenic KRASG12C inhibition using quantitative temporal proteomics", "year": "2020"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:1QpPpnLQ-OUC", "citedby": "0"}, {"bib": {"title": "Genomic and pathological heterogeneity in clinically diagnosed small cell lung cancer in never/light smokers identifies therapeutically targetable alterations", "year": "2020"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:WZ_cLlf9y-MC", "citedby": "0"}, {"bib": {"title": "Paradoxical activation of the protein kinase-transcription factor ERK5 by ERK5 kinase inhibitors", "year": "2020"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:l1aDfRkTpg0C", "citedby": "0"}, {"bib": {"title": "Pyrimido-diazepinone compounds and methods of treating disorders", "year": "2020"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:bZ-w8ItpEJYC", "citedby": "0"}, {"bib": {"title": "Correction: An ATP-competitive mammalian target of rapamycin inhibitor reveals rapamycin-resistant functions of mTORC1.", "year": "2020"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:UpNrVCuNAQgC", "citedby": "0"}, {"bib": {"title": "Pyrimido-diazepinone kinase scaffold compounds and methods of treating disorders", "year": "2020"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:SbtPZZD5bCsC", "citedby": "0"}, {"bib": {"title": "A broad-spectrum antiviral molecule, QL47, selectively inhibits eukaryotic translation", "year": "2020"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:SzdLQmZCmkwC", "citedby": "0"}, {"bib": {"title": "Inhibitors of cyclin-dependent kinases", "year": "2020"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:279hWsFo9KEC", "citedby": "0"}, {"bib": {"title": "Pyrimidines as EGFR inhibitors and methods of treating disorders", "year": "2020"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:D3btL2lJ8W4C", "citedby": "0"}, {"bib": {"title": "The combination of FLT3 and SYK kinase inhibitors is toxic to leukaemia cells with CBL mutations", "year": "2020"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:1vO5_MenwK0C", "citedby": "0"}, {"bib": {"title": "Fenpropimorph and fenhexamid impact phosphorus translocation by arbuscular mycorrhizal fungi. MYCORRHIZA. 21 (5) pp: 363-374.", "year": "2020"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:1PZZLG1Z4vcC", "citedby": "0"}, {"bib": {"title": "Tricyclic kinase inhibitors of MELK and methods of use", "year": "2020"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:tQ8TVJWhmt0C", "citedby": "0"}, {"bib": {"title": "Degradation of cyclin-dependent kinase 9 (CDK9) by conjugation of CDK9 inhibitors with E3 ligase ligand and methods of use", "year": "2020"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:g6z5zl4k3DgC", "citedby": "0"}, {"bib": {"title": "Benzopyrimidodiazepinone inhibitors of TNK2", "year": "2020"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:l15IaQQ0f8kC", "citedby": "0"}, {"bib": {"title": "Inhibitors of egfr and methods of use thereof", "year": "2020"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:XZpvIhjRgrsC", "citedby": "0"}, {"bib": {"title": "Salt-inducible kinase inhibition suppresses acute myeloid leukemia progression in vivo", "year": "2020"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:Ye8fVhOjtu8C", "citedby": "0"}, {"bib": {"title": "Sulfopin, a selective covalent inhibitor of Pin1, blocks Myc-driven tumor initiation and growth in vivo", "year": "2020"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:ilzMrZUAdaAC", "citedby": "0"}, {"bib": {"title": "Rapid and direct control of target protein levels with VHL-recruiting dTAG molecules", "year": "2020"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:hNW1902727sC", "citedby": "0"}, {"bib": {"title": "CM93, a novel covalent small molecule inhibitor targeting lung cancer with mutant EGFR", "year": "2020"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:bX5SDva7FKsC", "citedby": "0"}, {"bib": {"title": "Substituted 6, 11-dihydro-5H-benzo [b] carbazoles as inhibitors of ALK and SRPK", "year": "2019"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:iLjPvThLa1EC", "citedby": "0"}, {"bib": {"title": "Abstract C48: Defining mechanisms of adaptation to KRAS G12C inhibitors: Using quantitative proteomics to design combinatorial strategies in pancreatic cancer", "year": "2019"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:gWwPWYJ7j-oC", "citedby": "0"}, {"bib": {"title": "Degradation of protein kinases by conjugation of protein kinase inhibitors with e3 ligase ligand and methods of use", "year": "2019"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:u_MDJdmB8EcC", "citedby": "0"}, {"bib": {"title": "Imidazolyl kinase inhibitors and uses thereof", "year": "2019"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:3uvcc_vglMYC", "citedby": "0"}, {"bib": {"title": "Defining mechanisms of adaptation to KRAS G12C inhibitors: Using quantitative proteomics to design combinatorial strategies in pancreatic cancer", "year": "2019"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:gHzeFJ_WuCsC", "citedby": "0"}, {"bib": {"title": "Torin2 and related analogs exploit replicative and checkpoint vulnerabilities to induce death of triple negative breast cancer cells", "year": "2019"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:Jun0mLjAgmIC", "citedby": "0"}, {"bib": {"title": "Abstract B103: Torin2 and related analogs exploit replicative and checkpoint vulnerabilities to induce death of triple-negative breast cancer cells", "year": "2019"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:CBgv6AxxBp0C", "citedby": "0"}, {"bib": {"title": "Uses of salt-inducible kinase (sik) inhibitors", "year": "2019"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:9xgHvpYzqcUC", "citedby": "0"}, {"bib": {"title": "Targeting T-ALL Cells with Potent Activators of the PP2A Protein Phosphatase Tumor Suppressor", "year": "2019"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:dMyzg-cJZjAC", "citedby": "0"}, {"bib": {"title": "Systematic Characterization of Genes Representing Preferential Molecular Vulnerabilities for Myeloma Cells Compared to Other Neoplasias-Implications for the Biology and \u2026", "year": "2019"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:fDGgXDFiZ8cC", "citedby": "0"}, {"bib": {"title": "Functional Characterization of E3 Ligases and Their Regulators: Therapeutic Implications for Development of New Proteolysis-Targeting Chimeric Degraders of Oncoproteins", "year": "2019"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:hRqfHK2Mmv8C", "citedby": "0"}, {"bib": {"title": "Chemically Induced Degradation of MALT1 to Treat B-Cell Lymphomas", "year": "2019"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:fMXnj547Ig4C", "citedby": "0"}, {"bib": {"title": "Targeting Salt-Inducible Kinase 3 As a Therapeutic Approach for Acute Myeloid Leukemia", "year": "2019"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:CUa0UMr99BoC", "citedby": "0"}, {"bib": {"title": "Correction to Discovery of Immunologically Inspired Small Molecules That Target the Viral Envelope Protein", "year": "2019"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:2SPgszV3JSQC", "citedby": "0"}, {"bib": {"title": "Pyrimido-diazepinone compounds and methods of treating disorders", "year": "2019"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:n1hJTA2faNgC", "citedby": "0"}, {"bib": {"title": "Macrocyclic kinase inhibitors and uses thereof", "year": "2019"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:ms1Q_PLG2XUC", "citedby": "0"}, {"bib": {"title": "Compounds and methods for treating cancer", "year": "2019"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:X2rfhUWkJXEC", "citedby": "0"}, {"bib": {"title": "Pyrimido-diazepinone kinase scaffold compounds and methods of treating dclk1/2-mediated disorders", "year": "2019"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:tcItjQryOTkC", "citedby": "0"}, {"bib": {"title": "Bicyclic urea kinase inhibitors and uses thereof", "year": "2019"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:2LJqrQHhYIgC", "citedby": "0"}, {"bib": {"title": "Molecular markers of myeloma cell sensitivity vs. resistance to heterobifunctional degraders of oncoproteins: therapeutic implications.", "year": "2019"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:WIE79rvcIw4C", "citedby": "0"}, {"bib": {"title": "CRISPR studies identify genes preferentially essential for myeloma cells vs. other neoplasias: implications for future therapies selective against MM", "year": "2019"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:Nc8Yq6u9GesC", "citedby": "0"}, {"bib": {"title": "Genome wide chromatin accessibility profiling identifies chromatin signatures and novel transcription factor dependencies in multiple myeloma", "year": "2019"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:UPWeaTv7XkgC", "citedby": "0"}, {"bib": {"title": "Synthetic Lethal Interaction of SHOC2 Depletion with MEK Inhibition in RAS-Driven Cancers", "year": "2019"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:LlXdNf2Eqi8C", "citedby": "0"}, {"bib": {"title": "Inhibitors of interleukin-1 receptor-associated kinases and uses thereof", "year": "2019"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:viP-qiFw8s0C", "citedby": "0"}, {"bib": {"title": "Compounds for malt1 degradation", "year": "2019"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:uFXbyyTG2PgC", "citedby": "0"}, {"bib": {"title": "Degradation of bruton's tyrosine kinase (btk) by conjugation of btk inhibitors with e3 ligase ligand and methods of use", "year": "2019"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:3U-WyKnLcZ0C", "citedby": "0"}, {"bib": {"title": "Degradation of bruton's tyrosine kinase (btk) by conjugation of btk inhibitors with e3 ligase ligand and methods of use", "year": "2019"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:Ktjs2m5_fnEC", "citedby": "0"}, {"bib": {"title": "Kinase inhibitors for the treatment of disease", "year": "2019"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:kM62dKQefFYC", "citedby": "0"}, {"bib": {"title": "Inhibitors of EGFR and methods of use thereof", "year": "2019"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:h9UAY_4_kLEC", "citedby": "0"}, {"bib": {"title": "Inhibitors of c-jun-n-terminal kinase (jnk)", "year": "2019"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:thyth0UfN58C", "citedby": "0"}, {"bib": {"title": "Heteroaromatic compounds useful for the treatment of proliferative diseases", "year": "2019"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:OuH2OPd7BD0C", "citedby": "0"}, {"bib": {"title": "Synthesis and structure activity relationships of a series of 4-amino-1H-pyrazoles as covalent inhibitors of CDK14", "year": "2019"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:AdCmT_kuKwQC", "citedby": "0"}, {"bib": {"title": "Fused bicyclic pyrimidine derivatives and uses thereof", "year": "2019"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:IW6UN8mAVy8C", "citedby": "0"}, {"bib": {"title": "Discovery and characterization of covalent Pin1 inhibitors targeted to an active site cysteine", "year": "2019"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:iFAVf95Aq6sC", "citedby": "0"}, {"bib": {"title": "Novel pyrimidines as egfr inhibitors and methods of treating disorders", "year": "2019"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:5aZEtZeAH24C", "citedby": "0"}, {"bib": {"title": "Use of cdk8 inhibitors to treat diseases of inflammation and autoimmunity", "year": "2019"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:dz48QCY6SmAC", "citedby": "0"}, {"bib": {"title": "705 Cyclin-dependent kinase 9 (CDK9) as a therapeutic target in uveal and triple-wild type melanoma", "year": "2019"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:pdtoNNNhT-IC", "citedby": "0"}, {"bib": {"title": "Pyrimido-diazepinon kinase scaffold compounds and methods for treating p13k-mediated disorders", "year": "2019"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:lCzQINcJmSsC", "citedby": "0"}, {"bib": {"title": "Small molecule myristate inhibitors of bcr-abl and methods of use", "year": "2019"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:QJP_a5eTMeYC", "citedby": "0"}, {"bib": {"title": "EGFR Inhibitors and Methods of Treating Disorders", "year": "2019"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:UIDp_30-frIC", "citedby": "0"}, {"bib": {"title": "The Kinase Chemogenomic Set (KCGS): An open science resource for kinase vulnerability identification", "year": "2019"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:287Ayi2tS8MC", "citedby": "0"}, {"bib": {"title": "DCA promotes a novel tolerogenic program in CD4+ T cells by inhibiting CDK8", "year": "2019"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:Dp6ZCYcE31YC", "citedby": "0"}, {"bib": {"title": "STRIPAK directs PP2A activity toward MAP4K4 to promote oncogenic transformation", "year": "2019"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:STPpQ-Nbj3QC", "citedby": "0"}, {"bib": {"title": "Combined inhibition of mTOR and PIKKs exploits replicative and checkpoint vulnerabilities to induce death of PI3K-activated triple-negative breast cancer cells", "year": "2019"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:XLtXma4zydAC", "citedby": "0"}, {"bib": {"title": "The Salt-Inducible Kinase inhibitor YKL-05-099 suppresses MEF2C function and acute myeloid leukemia progression in vivo", "year": "2019"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:wi3gcRp_NToC", "citedby": "0"}, {"bib": {"title": "Tuning microtubule dynamics to enhance ovarian cancer therapy.", "year": "2018"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:VRZQuj8QWpIC", "citedby": "0"}, {"bib": {"title": "A Novel HCK Inhibitor Kin-8193 Blocks BTK Activity in BTKCys481 Mutated Ibrutinib Resistant B-Cell Lymphomas Driven By Mutated MYD88", "year": "2018"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:hwNCEvm7wWMC", "citedby": "0"}, {"bib": {"title": "Triple Degradation of BTK, IKZF1 and IKZF3 in B-Cell Malignancies", "year": "2018"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:CrdmdnJxex8C", "citedby": "0"}, {"bib": {"title": "Chromatin Accessibility Profiling Reveals Cis-Regulatory Heterogeneity and Novel Transcription Factor Dependencies in Multiple Myeloma", "year": "2018"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:wXeZnHswOLwC", "citedby": "0"}, {"bib": {"title": "Deng X; Gray NS; Espar\u00eds-Ogando A; David E; Pandiella A; Dello Sbarba P; Parola M; Marra F.. The mitogen-activated protein kinase ERK5 regulates the development and growth of \u2026", "year": "2018"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:ftAh3kAbccMC", "citedby": "0"}, {"bib": {"title": "Salt inducible kinases control responses to parathyroid hormone in the renal proximal tubule", "year": "2018"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:sdbE4nmAF2cC", "citedby": "0"}, {"bib": {"title": "Host targeted inhibitors of dengue virus and other viruses", "year": "2018"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:-YxgYmOPpg0C", "citedby": "0"}, {"bib": {"title": "Malt1 inhibitors and uses thereof", "year": "2018"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:ZUxERvGTmvgC", "citedby": "0"}, {"bib": {"title": "Lrrk2 inhibitors and methods of making and using the same", "year": "2018"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:_qBtHxPZqFwC", "citedby": "0"}, {"bib": {"title": "Methods to treat lymphoplasmacytic lymphoma", "year": "2018"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:gOXF9J3PlnEC", "citedby": "0"}, {"bib": {"title": "Genomewide CRISPR studies of sequential treatment with CRBN-based degronimids: Insights into the molecular evolution of treatment resistance in myeloma and beyond", "year": "2018"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:jldLm8U3Uk0C", "citedby": "0"}, {"bib": {"title": "High-throughput immune-oncology screen identifies EGFR inhibitors as potent enhancers of CTL antigen-specific tumor cell killing", "year": "2018"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:_jjH_pYez2EC", "citedby": "0"}, {"bib": {"title": "Combined inhibition of MEK and mTOR pathways is effective in NRAS Q61K mutant small cell lung cancer", "year": "2018"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:f37qlrqcxlUC", "citedby": "0"}, {"bib": {"title": "PO-099 Targeting the mitogen activated protein kinase ERK5 in human melanoma", "year": "2018"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:BgQ7vgDDwsMC", "citedby": "0"}, {"bib": {"title": "PO-145 ERK5 pathway inhibitors inhibit the maintenance of chronic myeloid leukaemia stem cells", "year": "2018"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:WKZfnVNUP7sC", "citedby": "0"}, {"bib": {"title": "Salicylate inhibitors of melk and methods of use", "year": "2018"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:TxN98J45HB8C", "citedby": "0"}, {"bib": {"title": "Stk4 inhibitors for treatment of hematologic malignancies", "year": "2018"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:4Ol-GlP6dRYC", "citedby": "0"}, {"bib": {"title": "4, 6-pyrimidinylene derivatives and uses thereof", "year": "2018"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:qz_RHJpDe1QC", "citedby": "0"}, {"bib": {"title": "MELK is an oncogenic kinase essential for mitotic progression in basal-like breast cancer cells (vol 3, e01763, 2014)", "year": "2018"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:H_lu47GSfL8C", "citedby": "0"}, {"bib": {"title": "Cyclin-dependent kinase 12 (CDK12), human kinase domain; a Target Enabling Package", "year": "2018"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:hc6fSYdAWgkC", "citedby": "0"}, {"bib": {"title": "Abstract PR04: Degradation of leukemia oncogenes: A novel approach to therapy of leukemia", "year": "2017"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:p-RlQlBqj_YC", "citedby": "0"}, {"bib": {"title": "Small molecule myristate inhibitors of bcr-abl and abl and methods of use", "year": "2017"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:Y4TYaDvN-EgC", "citedby": "0"}, {"bib": {"title": "A Unique N-Phenylbenzamide Inhibitor Targeting Non-Receptor Tyrosine Kinases Potently Suppresses AML Cell Growth In Vitro and In Vivo", "year": "2017"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:y_m0fafCJJkC", "citedby": "0"}, {"bib": {"title": "Systematic Characterization of the Resistome of Tumor Cells Against Panels of Small Molecule Inhibitors\u2014Application in the Context of Inhibitors of Transcriptional Cyclin \u2026", "year": "2017"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:bjbQ1S6M1lUC", "citedby": "0"}, {"bib": {"title": "Integration of Functional Dependencies and Molecular Alterations of Myeloma Cells", "year": "2017"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:5s5aUJDWGkQC", "citedby": "0"}, {"bib": {"title": "The small molecule SIK inhibitor YKL-05-099 increases trabecular bone mass and bone formation in hypogonadal female mice.", "year": "2017"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:XU5Z2mhinIMC", "citedby": "0"}, {"bib": {"title": "Degradation of leukemia oncogenes: A novel approach to therapy of leukemia.", "year": "2017"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:dfXa6b-OQWMC", "citedby": "0"}, {"bib": {"title": "YKL-05-099 uncouples bone formation and resorption by blocking M-CSF-driven osteoclastogenesis.", "year": "2017"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:nLH0p24aEWsC", "citedby": "0"}, {"bib": {"title": "Identification of super-enhancer-associated cancer genes provides novel therapeutic targets in adult T-cell leukemia/lymphoma", "year": "2017"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:z5TOL5VncIsC", "citedby": "0"}, {"bib": {"title": "Developing kinase inhibitors with polypharmacological profiles for the treatment of resistant cancers", "year": "2017"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:e0V1A8vmkmEC", "citedby": "0"}, {"bib": {"title": "Inhibition of the ERK5 pathway as a novel approach to target human chronic myeloid leukemia stem cells", "year": "2017"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:Zk90fmyTIMwC", "citedby": "0"}, {"bib": {"title": "Suppression of adaptive responses to targeted therapies by transcriptional inhibition", "year": "2017"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:AYV8G9fXOwEC", "citedby": "0"}, {"bib": {"title": "Synthetic lethality of CDK12 inhibition in tumors with EWS/FLI rearrangements", "year": "2017"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:YI35Bd-2PncC", "citedby": "0"}, {"bib": {"title": "Small molecule myristate inhibitors of Bcr-abl and methods of use", "year": "2017"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:BEz2JxMiyrUC", "citedby": "0"}, {"bib": {"title": "Uses of kinase inhibitors for inducing and maintaining pluripotency", "year": "2017"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:VcGLcUShYXsC", "citedby": "0"}, {"bib": {"title": "YY1 Is a Structural Regulator of Enhancer-Promoter Loops", "year": "2017"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:xMaaESzsSl8C", "citedby": "0"}, {"bib": {"title": "Aberrant Phosphorylation of MEF2C Is Dispensable for Hematopoiesis, and Induces Chemotherapy Resistance and Susceptibility to MARK Kinase Inhibition Therapy in Acute Myeloid \u2026", "year": "2016"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:GU5qFXB69o4C", "citedby": "0"}, {"bib": {"title": "Dihydropteridinone derivatives and uses thereof", "year": "2016"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:_5f0VhOe6mUC", "citedby": "0"}, {"bib": {"title": "Covalent targeting of remote cysteine residues to develop CDK12 and 13 inhibitors", "year": "2016"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:m6NpXP4PQyIC", "citedby": "0"}, {"bib": {"title": "TGF\u00e2 upregulation mediates growth retardation in EGFR T790M mutant non-small cell lung cancer", "year": "2016"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:lN037PIkXpQC", "citedby": "0"}, {"bib": {"title": "MEK5-ERK5 inhibitors target chronic myeloid leukemia stem cells and in combination with imatinib reduce the expression of stem cell genes", "year": "2016"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:b6LYR6tDxhYC", "citedby": "0"}, {"bib": {"title": "LG-47TYPE II RAF INHIBITORS INHIBIT BRAF MUTATIONS AND TRUNCATED FUSIONS IN PEDIATRIC LOW-GRADE GLIOMAS", "year": "2016"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:9nzIJd-pbyIC", "citedby": "0"}, {"bib": {"title": "Effect of Covalent TAK1 Inhibitors on the Viability of Pancreatic, Renal and Colon Cancer Cells", "year": "2016"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:DHCjA4HYnd0C", "citedby": "0"}, {"bib": {"title": "Abstract PR04: Targeting super-enhancer driven oncogene transcription through cyclin-dependent kinase inhibitors", "year": "2016"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:NOsVDcwM7ZYC", "citedby": "0"}, {"bib": {"title": "Human Cyclin-dependent kinase 12 (CDK12), kinase domain", "year": "2016"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:5lpRS_NW7LAC", "citedby": "0"}, {"bib": {"title": "New Approaches to Challenging Targets in Cancer", "year": "2016"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:BAB3QVgpZKkC", "citedby": "0"}, {"bib": {"title": "Genomic and Proteomic Analysis of Primary Chemoresistance and Induction Failure in Acute Myeloid Leukemia", "year": "2015"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:CS3DEtbQARgC", "citedby": "0"}, {"bib": {"title": "Targeting Myddosome Self-assembly in Waldenstr\u00f6m's Macroglobulinemia", "year": "2015"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:rIeyUKJ4rSMC", "citedby": "0"}, {"bib": {"title": "Abstract B74: Combined inhibition of ALK and CDKs involved in transcriptional regulation is synergistic in ALK-mutated neuroblastoma", "year": "2015"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:qkdS9U4CG6gC", "citedby": "0"}, {"bib": {"title": "Abstract A178: Structure guided development of irreversible inhibitors for TAK1", "year": "2015"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:NpQWRVIN-bwC", "citedby": "0"}, {"bib": {"title": "Abstract B180: Multi-targeted tyrosine kinase inhibitors potently suppress FLT3-ITD+ AML cell growth", "year": "2015"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:ZKH7YajmJZgC", "citedby": "0"}, {"bib": {"title": "Abstract LB-C24: Resistance to ALK inhibition is associated with enhanced BRD4 dependence in ALK-mutated MYCN-amplified neuroblastoma", "year": "2015"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:p11oD0Q27JMC", "citedby": "0"}, {"bib": {"title": "Inhibition of Phosphatidylinositol-5-Phosphate 4-Kinases (PI5P4K\u03b1 and \u03b2) Inhibits Proliferation and Radiosensitizes Triple Negative Breast Cancer Cells Harboring p53 Mutations", "year": "2015"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:BPS1z4jHU5cC", "citedby": "0"}, {"bib": {"title": "Abstract PR05: Targeting of CDK7 inhibits super-enhancer-associated oncogenic programs in MYCN-amplified tumor cells", "year": "2015"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:WMtz-WDmgKQC", "citedby": "0"}, {"bib": {"title": "Dual inhibition of Flt3 and Fes tyrosine kinases potently blocks proliferation of AML cells expressing an active Flt3 mutant.", "year": "2015"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:z3Vh2AeS4YoC", "citedby": "0"}, {"bib": {"title": "Identification of Existing Targeted Drugs That Inhibit NTRK and ROS1 in Lung Cancer", "year": "2015"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:GbL5_m8SeH4C", "citedby": "0"}, {"bib": {"title": "Abstract A25: Dual inhibition of Flt3 and Fes tyrosine kinases potently blocks proliferation of AML cells expressing an active Flt3 mutant.", "year": "2015"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:adHtZc2wMuEC", "citedby": "0"}, {"bib": {"title": "Torin2 suppresses ionizing radiation induced DNA damage repair", "year": "2015"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:3BvdIg-l-ZAC", "citedby": "0"}, {"bib": {"title": "A high-throughput chemical screen identifies synergistic activity between crizotinib and transcriptional CDK inhibitors in ALK-mutated neuroblastoma", "year": "2015"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:QKtdBID3u5MC", "citedby": "0"}, {"bib": {"title": "Distinct roles of c-Jun N-terminal kinase (JNK) isoforms in skin cancer", "year": "2015"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:Gb6Hms-Uo9kC", "citedby": "0"}, {"bib": {"title": "Identification of existing targeted agents that inhibit NTRK and ROS1 in lung cancer", "year": "2015"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:_mQi-xiA4oYC", "citedby": "0"}, {"bib": {"title": "Single-cell analysis of adaptive resistance and fractional responses of melanoma cells to RAF/MEK inhibition", "year": "2015"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:N6_Y7JlWxwsC", "citedby": "0"}, {"bib": {"title": "Abstract A12: Genetic and pharmacologic inhibition of EPHA2 promotes apoptosis in NSCLC", "year": "2015"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:4QKQTXcH0q8C", "citedby": "0"}, {"bib": {"title": "Oncogene starvation via selective CDK7 inhibition: A novel approach for targeting traditionally undruggable oncogenic molecules in melanoma", "year": "2015"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:a2necdfpwlEC", "citedby": "0"}, {"bib": {"title": "Identification of Wee1 and IGF-1R As Novel Therapeutic Targets for Mutant RAS-Driven Acute Leukemia By Combinatory Chemical Screens", "year": "2014"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:cSdaV2aYdYsC", "citedby": "0"}, {"bib": {"title": "Citron Rho-Interacting Serine/Threonine kinase (CIT) Is a Novel Therapeutic Target in Multiple Myeloma Cells", "year": "2014"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:K4-iKlO5MD4C", "citedby": "0"}, {"bib": {"title": "Development and Repurposing of Small-Molecule Kinase Inhibitors to Target Novel Leukemogenic TNK2 Mutations", "year": "2014"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:BW2nPTmhBn4C", "citedby": "0"}, {"bib": {"title": "Abstract PR07: Crystal structure of K-Ras G12C bound to an active site inhibitor", "year": "2014"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:3vbIHxFL9FgC", "citedby": "0"}, {"bib": {"title": "298 Met degradation by SAIT301, a Met monoclonal antibody, reduces the invasion and migration of nasopharyngeal cancer cells via inhibition of EGR-1 expression", "year": "2014"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:3MwzVuqRcA0C", "citedby": "0"}, {"bib": {"title": "297 Genetic and pharmacologic inhibition of EPHA2 promotes apoptosis in NSCLC", "year": "2014"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:w2UhwfzvF0QC", "citedby": "0"}, {"bib": {"title": "JNK-IN-8: a novel covalent inhibitor targeting JNK signaling in triple-negative breast cancer", "year": "2014"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:oursBaop5wYC", "citedby": "0"}, {"bib": {"title": "A high-throughput chemical screen identifies synergistic activity between neurotransmitter receptor inhibitors and crizotinib in ALK-mutated neuroblastoma", "year": "2014"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:0ngZmJvimKcC", "citedby": "0"}, {"bib": {"title": "Genomic mechanisms of exquisite sensitivity and acquired resistance to everolimus in a patient with anaplastic thyroid carcinoma", "year": "2014"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:MDX3w3dAD3YC", "citedby": "0"}, {"bib": {"title": "Abstract LB-125: Selective inhibition of CDK7 targets MYCN-driven transcriptional amplification in neuroblastoma", "year": "2014"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:ukw-9cB-YDkC", "citedby": "0"}, {"bib": {"title": "Cover Picture: Chemical Interrogation of the Malaria Kinome (ChemBioChem 13/2014)", "year": "2014"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:e84hm74t-eoC", "citedby": "0"}, {"bib": {"title": "Systematic characterization of drug-induced adaptive responses in melanoma: TUE-222", "year": "2014"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:CRzUtm-VnGAC", "citedby": "0"}, {"bib": {"title": "PMCID: PMC4230581.", "year": "2014"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:yIeBiWEAh44C", "citedby": "0"}, {"bib": {"title": "TARGETING BRAF MUTANTS FOR PEDIATRIC LOW-GRADE ASTROCYTOMAS", "year": "2014"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:rbGdIwl2e6cC", "citedby": "0"}, {"bib": {"title": "Small Molecule Inhibitors of USP1 Target ID1 Degradation in Leukemic Cells and Cause Cytotoxicity", "year": "2013"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:9shLKfS_uJEC", "citedby": "0"}, {"bib": {"title": "Germinal Center Kinase Regulates The Proliferation and Survival Of Diffuse Large B-Cell Lymphoma", "year": "2013"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:PlWzFYVEG4EC", "citedby": "0"}, {"bib": {"title": "Using Small Molecules To Identify Critical Signaling Pathways Of Mutant N-RAS In Acute Leukemia Cells", "year": "2013"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:KTwcwpFFj4wC", "citedby": "0"}, {"bib": {"title": "2-biphenylamino-4-aminopyrimidine derivatives as kinase inhibitors", "year": "2013"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:olpn-zPbct0C", "citedby": "0"}, {"bib": {"title": "Pharmacologic inhibition of EphA2 in NRAS and BRAF mutant melanomas.", "year": "2013"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:vnF2_uLGgtgC", "citedby": "0"}, {"bib": {"title": "Dual inhibitors of Flt3 and c-Fest tyrosine kinases potently inhibit proliferation of AML cells expressing an active Flt3 mutant.", "year": "2013"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:PuOEWVtPfzwC", "citedby": "0"}, {"bib": {"title": "The AXL tyrosine kinase receptor contributes to ALK-inhibitor resistance in neuroblastoma.", "year": "2013"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:BAanoTsO0WEC", "citedby": "0"}, {"bib": {"title": "0139. DEVELOPMENT OF COMBINED PK/PD STUDIES OF RAF/MEK/mTOR INHIBITORS FOR THE TREATMENT OF PEDIATRIC LOW-GRADE ASTROCYTOMAS BY MALDI MASS SPECTROMETRY IMAGING", "year": "2013"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:5bg8sr1QxYwC", "citedby": "0"}, {"bib": {"title": "Discovery of a Potent and Selective DDR1 Receptor Tyrosine Kinase of a Potent and Selective DDR1 Receptor Tyrosine Kinase", "year": "2013"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:Gt7F3adpS1AC", "citedby": "0"}, {"bib": {"title": "Development of Fluorescent Probes for Cancer Cell Lines", "year": "2013"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:69ZgNCALVd0C", "citedby": "0"}, {"bib": {"title": "Deciphering the Critical Pathways of Mutant N-RAS in AML Using Small Molecule Inhibitors.", "year": "2012"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:F2UWTTQJPOcC", "citedby": "0"}, {"bib": {"title": "TYK2-STAT1 Pathway Positively Regulates BCL2 Gene Expression in T-Cell Acute Lymphoblastic Leukemia", "year": "2012"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:FiDNX6EVdGUC", "citedby": "0"}, {"bib": {"title": "225 Diversity in Individual Src-family Kinase Regulation: Opportunities for Selective Inhibitor Discovery", "year": "2012"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:OR75R8vi5nAC", "citedby": "0"}, {"bib": {"title": "Design and Selection of Small Molecule Inhibitors", "year": "2012"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:OTTXONDVkokC", "citedby": "0"}, {"bib": {"title": "P089 Identification of the first protein kinase inhibitors that switch macrophages from pro-inflammatory to anti-inflammatory cytokine production", "year": "2012"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:IUKN3-7HHlwC", "citedby": "0"}, {"bib": {"title": "Development and characterization of covalent kinase inhibitors", "year": "2012"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:In6cVmBjs0IC", "citedby": "0"}, {"bib": {"title": "IDENTIFICATION OF NEW INHIBITORS OF RET RECEPTOR TYROSINE KINASE: OP51", "year": "2012"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:zmJoL7Ye8dcC", "citedby": "0"}, {"bib": {"title": "Selective small-molecule kinase inhibitors of the c-Src: FAK complex", "year": "2012"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:CMvovTBb2okC", "citedby": "0"}, {"bib": {"title": "The ATP-competitive mTOR inhibitor Torin2 enhances sensitivity of the ALK F1174L mutation to crizotinib in neuroblastoma", "year": "2012"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:rqnDXT1GswoC", "citedby": "0"}, {"bib": {"title": "FGFR3 as a therapeutic target in squamous cell lung carcinoma", "year": "2012"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:AFmTUeZ1pmEC", "citedby": "0"}, {"bib": {"title": "Abstract B13: FGFR2 as a therapeutic target in squamous cell lung carcinoma", "year": "2012"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:j7_hQOaDUrUC", "citedby": "0"}, {"bib": {"title": "characterization of an isoform-selective inhibitor of Pi3K-p110b as a Potential anticancer agent", "year": "2012"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:NVvf8e-c9oUC", "citedby": "0"}, {"bib": {"title": "Selectivity and binding kinetics of mTOR inhibitors", "year": "2012"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:08ThfGyFJksC", "citedby": "0"}, {"bib": {"title": "Jing Ni1, 2, Qingsong Liu1, 2, Shaozhen Xie1, 2, Coby Carlson4, Thanh Von1, 2, Kurt Vogel4, Steve Riddle4, Cyril Benes3, Michael Eck1, 2", "year": "2012"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:ksVBBY9DlqUC", "citedby": "0"}, {"bib": {"title": "Abstract A234: Identification and characterization of inhibitor-resistant mutants of the protein-tyrosine kinase c-Fes.", "year": "2011"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:oqD4_j7ulsYC", "citedby": "0"}, {"bib": {"title": "Overcoming kinase inhibitor resistance: EGFR, Bcr-Abl, and b-Raf", "year": "2011"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:KNjnJ3z-R6IC", "citedby": "0"}, {"bib": {"title": "Secondary mutations in ALK and resistance to ALK kinase inhibitors", "year": "2011"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:qCpRzq7zkD8C", "citedby": "0"}, {"bib": {"title": "Discovery and optimization of potent and selective benzonaphthyridinone analogs as dual mTOR/ATR small molecular inhibitors for treatment of cancer", "year": "2011"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:tBlTYpvFGQIC", "citedby": "0"}, {"bib": {"title": "Pathway dependence on the tyrosine kinase TYK2 in T-cell acute lymphoblastic leukemia", "year": "2011"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:gV6rEsy15s0C", "citedby": "0"}, {"bib": {"title": "Amplification of ERK2 mediates resistance to the novel irreversible EGFR inhibitor WZ4002", "year": "2011"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:l6Q3WhenKVUC", "citedby": "0"}, {"bib": {"title": "Mutations in the DDR2Kinase Gene identify a Novel therapeutic target in squamous cell lung cancer", "year": "2011"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:g5h4crcM1N4C", "citedby": "0"}, {"bib": {"title": "Compounds and compositions as protein kinase inhbitors", "year": "2010"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:_axFR9aDTf0C", "citedby": "0"}, {"bib": {"title": "Use of FDG-PET for early response assessment of novel EGFR kinase inhibitors in mouse models of lung cancer", "year": "2010"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:aDl3D7KC1E4C", "citedby": "0"}, {"bib": {"title": "Quantitative kinase inhibitor profiling in native cell and tissue extracts", "year": "2010"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:yJjnfzR0HrkC", "citedby": "0"}, {"bib": {"title": "Small molecule inhibitors of the Fes non-receptor tyrosine kinase", "year": "2010"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:sgsej9ZJWHMC", "citedby": "0"}, {"bib": {"title": "Screening and rational design approaches for developing selective protein kinase inhibitors", "year": "2010"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:RoXSNcbkSzsC", "citedby": "0"}, {"bib": {"title": "Abstract B165: Abl kinase myristate\u2010site inhibitor, mechanism and application", "year": "2009"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:bXQfdp6S9ecC", "citedby": "0"}, {"bib": {"title": "A CERAMIDE-1-PHOSPHATE ANALOG, PCERA-1, SUPPRESSES TNF alpha AND INDUCES IL-10 PRODUCTION IN ACTIVATED MACRO-PHAGES", "year": "2009"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:1DsIQWDZLl8C", "citedby": "0"}, {"bib": {"title": "Fibroblast growth factor receptor 1-transformed mammary epithelial cells are dependent on RSK activity for growth and survival (vol 69, pg 2244, 2009)", "year": "2009"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:PyEswDtIyv0C", "citedby": "0"}, {"bib": {"title": "Ten Best Readings Relating to Chronic Myeloid Leukemia (CML)", "year": "2009"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:uLbwQdceFCQC", "citedby": "0"}, {"bib": {"title": "Inhibition of BCR/ABL-T315I by Dismantling the Hydrophobic Spine.", "year": "2008"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:HhcuHIWmDEUC", "citedby": "0"}, {"bib": {"title": "Activity of Plk Inhibitor BI2536 on Myeloma Cells", "year": "2008"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:sszUF3NjhM4C", "citedby": "0"}, {"bib": {"title": "Compositions and methods for inducing osteogenesis", "year": "2008"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:am5FR3_r3McC", "citedby": "0"}, {"bib": {"title": "MEDI 20-Discovery and characterization of allosteric inhibitors of Bcr-Abl kinase", "year": "2008"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:3bvyWxjaHKcC", "citedby": "0"}, {"bib": {"title": "COMP 376-Chemical approaches for making\" inactive-conformation\" kinase inhibitors", "year": "2008"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:pAkWuXOU-OoC", "citedby": "0"}, {"bib": {"title": "Proteomic approaches to kinase inhibitors (targeting the kinome using ATP and non-ATP competitive inhibitors).", "year": "2008"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:rFyVMFCKTwsC", "citedby": "0"}, {"bib": {"title": "The BMX Tec family kinase mediates PI (3)-Kinase-dependent transformation in an epithelial cell line model.", "year": "2008"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:9LpHyFPp1DQC", "citedby": "0"}, {"bib": {"title": "A Unified Mechanism of Tyrosine Kinase Regulation by the Gatekeeper Residue.", "year": "2007"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:AvfA0Oy_GE0C", "citedby": "0"}, {"bib": {"title": "BIOL 5-Chemical approaches toward the design of selective and nonselective protein kinase inhibitors", "year": "2007"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:NDuN12AVoxsC", "citedby": "0"}, {"bib": {"title": "Proteomics Characterization of Oncogenic Kinase Inhibitors", "year": "2007"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:M7yex6snE4oC", "citedby": "0"}, {"bib": {"title": "Role of sphingosine-1-phosphate receptor modulators in the prevention of transplant rejection", "year": "2006"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:kWvqk_afx_IC", "citedby": "0"}, {"bib": {"title": "Purine inhibitors of protein kinases, G proteins and polymerases", "year": "2005"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:0-VSGmPhd2EC", "citedby": "0"}, {"bib": {"title": "A screen for small molecule inhibitors that disrupt the interaction between Ran-GTP and importin-beta", "year": "2004"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:VN7nJs4JPk0C", "citedby": "0"}, {"bib": {"title": "Sphingosine 1-Phosphate (S1P) Receptor Subtypes S1P", "year": "2004"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:hMsQuOkrut0C", "citedby": "0"}, {"bib": {"title": "Targeting Specific Amino Acid Residues in Designing Selective Protein Kinase Inhibitors", "year": "2004"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:tKAzc9rXhukC", "citedby": "0"}, {"bib": {"title": "Cell-based assays in cancer drug discovery.", "year": "2003"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:U_HPUtbDl20C", "citedby": "0"}, {"bib": {"title": "Optimization of experimental antimitotic agents: classical and combinatorial methods.", "year": "2003"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:edDO8Oi4QzsC", "citedby": "0"}, {"bib": {"title": "VACCINES AND ANTIVIRAL AGENTS-Pharmacological Cyclin-Dependent Kinase Inhibitors Inhibit Replication of Wild-Type and Drug-Resistant Strains of Herpes Simplex Virus and Human \u2026", "year": "2002"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:k8Z6L05lTy4C", "citedby": "0"}, {"bib": {"title": "Chemical genetics using cytoplasmic extracts: Identification of a novel protein regulating microtubule stability", "year": "2001"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:-95Q15plzcUC", "citedby": "0"}, {"bib": {"title": "Sangankar, l Omar Perez, 5 Rebecca Heald, 3 Peter G. Schultz* 2'4", "year": "2001"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:Vno172sVVMwC", "citedby": "0"}, {"bib": {"title": "Tetrahedron Letters 42 (2001) 8743 Asymmetric synthesis of cis-aminochromanol", "year": "2001"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:WAzi4Gm8nLoC", "citedby": "0"}, {"bib": {"title": "A chemistry-based approach to identify factors involved in spindle assembly", "year": "1999"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:uVUOdF_882EC", "citedby": "0"}, {"bib": {"title": "mRNA expression profile of a human cancer cell line in response to a phytochemical extract with antioxidant properties", "year": "1999"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:foquWX3nUaYC", "citedby": "0"}, {"bib": {"title": "Characterization of a novel cdk inhibitor using Xenopus egg extracts.", "year": "1998"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:w0F2JDEymm0C", "citedby": "0"}, {"bib": {"title": "A GENETIC APPROACH TO THE GENERATION OF ANTIBODIES WITH ENHANCED CATALYTIC ACTIVITIES", "year": "1994"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:mKu_rENv82IC", "citedby": "0"}, {"bib": {"title": "Catalytic Domain Plasticity of MKK7 Reveals Structural Mechanisms of Allosteric Activation and New Targeting Opportunities"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:zl-nTW-_jeEC", "citedby": "0"}, {"bib": {"title": "Covalent targeting of fibroblast growth factor receptor inhibits metastatic breast cancer"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:glXaSHlJq2UC", "citedby": "0"}, {"bib": {"title": "The I mmu no l og i ca l EVO lu ti on reconstr, lct, he~ mrn~ 1n, 1o~~ cal"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:Y2FWPFNJqs4C", "citedby": "0"}, {"bib": {"title": "Structural and atropisomeric factors governing the selectivity profile of pyrimido-benzodiazipinones as inhibitors of kinases and bromo-domains"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:SbDlCG0g-rIC", "citedby": "0"}, {"bib": {"title": "Targeting Vulnerabilities in Successive Cell Cycle Stages to Induce Death of PI3K-Activated Basal-Like Breast Cancer Cells"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:qoKP6G9emhYC", "citedby": "0"}, {"bib": {"title": "Supplemental Information A Small-Molecule Inducer of the Antioxidant Response Element"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:xx6dpm3-DsgC", "citedby": "0"}, {"bib": {"title": "Selective ATP-competitive inhibitors of TOR suppress rapamycin insensitive function of TORC2 in S. cerevisiae"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:KT8ZRUJCfZgC", "citedby": "0"}, {"bib": {"title": "cells 2"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:VFeYHPVE0z4C", "citedby": "0"}, {"bib": {"title": "Inventory of Supplemental Information Figure S1: Identification of Fes inhibitors using the Z-LYTE\u2122 in vitro kinase assay and a recombinant Fes SH2-kinase domain (SH2-KD \u2026"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:-ssuBh8vdzEC", "citedby": "0"}, {"bib": {"title": "Supplemental Information YAP Drives Growth by Controlling Transcriptional Pause Release from Dynamic Enhancers"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:FiDtFDW-5cwC", "citedby": "0"}, {"bib": {"title": "Supplemental Information A Structure-Guided Approach to Creating Covalent FGFR Inhibitors"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:4oiV7xVJuUIC", "citedby": "0"}, {"bib": {"title": "Exploration of Type II Binding Mode: a Privileged Approach for Kinase Inhibitor Focused Drug Discovery? Supplemental information"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:trmuqZugEg0C", "citedby": "0"}, {"bib": {"title": "Expanding the Diversity of Allosteric Bcr-Abl Inhibitors"}, "source": "citations", "id_citations": "spRDlWkAAAAJ:52Op3ZsrznwC", "citedby": "0"}]}